alanine aminotransferase (alt or sgpt)

25
PARTICIPANT STATISTICS Chemistry Q2 2010 COMPREHENSIVE CHEMISTRY Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5 Name Line No. Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD No. of Labs Alanine Aminotransferase (ALT or SGPT) Initial Grouping by Reagent and Instrument Abbott no P5P & Abbott Architect c, ci, i 1 116.0 - 174.0 P 145.1 4.5 51.0 - 77.0 P 63.8 2.7 66.0 - 99.0 P 82.2 2.9 146.0 - 219.0 P 182.5 4.3 164.0 - 245.0 P 204.4 5.2 17 Alfa Wassermann & Alfa Wasser ACE/Centr/Alera 2 105.0 - 158.0 P 131.9 5.1 49.0 - 73.0 P 60.9 3.6 60.0 - 91.0 P 75.5 3.4 129.0 - 194.0 P 161.8 6.1 148.0 - 222.0 P 185.3 6.9 80 Beckman no P5P & Beckman Synchron CX4/CX5 3 107.0 - 161.0 P 133.8 2.8 48.0 - 71.0 P 59.6 1.4 61.0 - 91.0 P 76.0 2.1 134.0 - 201.0 P 167.4 3.4 151.0 - 227.0 P 189.1 4.2 19 Beckman no P5P & Beckman Synchron CX3/7/9/L 4 106.0 - 160.0 P 133.0 3.9 47.0 - 71.0 P 59.0 2.1 60.0 - 90.0 P 75.4 2.3 133.0 - 199.0 P 166.1 4.3 150.0 - 225.0 P 187.1 4.7 29 Beckman no P5P & Beckman Unicel DXC series 5 112.0 - 168.0 P 139.7 2.9 50.0 - 75.0 P 62.6 1.6 64.0 - 96.0 P 79.6 1.9 140.0 - 210.0 P 174.7 3.4 157.0 - 235.0 P 196.2 4.2 67 Clinical Data ATAC & Vital Diagnostics ATAC 8000 6 110.0 - 165.0 P 137.2 8.3 48.0 - 72.0 P 60.2 3.7 61.0 - 92.0 P 76.6 4.5 135.0 - 203.0 P 169.2 9.8 153.0 - 230.0 P 191.6 13.1 19 Clinical Data Envoy & Vital Diagnostics Envoy 500 7 120.0 - 179.0 P 149.5 3.7 52.0 - 78.0 P 64.9 1.8 67.0 - 101.0 P 84.2 2.5 149.0 - 224.0 P 186.4 4.8 168.0 - 252.0 P 209.8 5.4 13 DCL/Genzyme & Roche Cobas Mira series 8 104.0 - 156.0 P 130.2 3.4 47.0 - 70.0 P 58.2 1.3 59.0 - 89.0 P 74.1 1.8 131.0 - 197.0 P 164.1 4.6 147.0 - 221.0 P 184.0 3.8 10 Horriba ABX & Horiba ABX Pentra 400 9 123.0 - 184.0 P 153.7 4.4 54.0 - 81.0 P 67.4 2.3 68.0 - 102.0 P 85.1 3.0 152.0 - 228.0 P 190.0 6.1 172.0 - 259.0 P 215.5 5.8 13 J&J Vitros & J&J Vitros not DT or ECi 10 120.0 - 180.0 P 149.9 3.5 54.0 - 81.0 P 67.3 3.0 67.0 - 100.0 P 83.7 3.4 148.0 - 223.0 P 185.6 3.9 170.0 - 255.0 P 212.6 4.6 81 J&J Vitros & J&J Vitros 5,1 FS 11 120.0 - 180.0 P 150.4 4.1 56.0 - 84.0 P 70.3 4.3 69.0 - 103.0 P 86.1 3.8 150.0 - 226.0 P 188.1 4.9 170.0 - 255.0 P 212.5 5.6 17 Beckman Olympus & Beck Oly AU 400/600/5400 12 102.0 - 153.0 P 127.8 5.2 44.0 - 67.0 P 55.5 2.6 57.0 - 85.0 P 71.2 2.9 127.0 - 191.0 P 159.0 6.3 143.0 - 215.0 P 179.3 7.0 46 Roche Cobas & Roche Cobas 6000 13 117.0 - 175.0 P 145.7 3.7 50.0 - 76.0 P 63.1 1.9 65.0 - 97.0 P 80.7 2.2 145.0 - 217.0 P 181.2 4.7 164.0 - 245.0 P 204.4 5.3 10 Roche Cobas & Roche Cobas Integra 14 116.0 - 174.0 P 145.0 2.6 50.0 - 75.0 P 62.7 1.2 64.0 - 96.0 P 80.1 1.3 144.0 - 216.0 P 179.6 2.5 163.0 - 245.0 P 204.1 3.5 27 SDI Biomed & SDI CA240, 480 15 97.0 - 146.0 P 121.6 10.5 45.0 - 67.0 P 55.8 4.8 58.0 - 86.0 P 72.1 6.4 123.0 - 185.0 P 153.9 10.8 135.0 - 202.0 P 168.4 16.4 17 Siemens no P5P & Siemens Advia series 16 118.0 - 177.0 P 147.3 4.0 52.0 - 78.0 P 65.2 3.0 67.0 - 100.0 P 83.2 3.4 146.0 - 219.0 P 182.4 6.2 164.0 - 246.0 P 205.2 8.6 17 Siemens Dimension & Siemens Dimension series 17 126.0 - 188.0 P 157.0 3.9 62.0 - 92.0 P 76.9 2.7 76.0 - 115.0 P 95.6 3.2 155.0 - 233.0 P 193.8 5.7 173.0 - 259.0 P 215.9 5.3 80

Upload: others

Post on 12-Sep-2021

8 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Alanine Aminotransferase (ALT or SGPT)

PARTICIPANT STATISTICS Chemistry Q2 2010

COMPREHENSIVE CHEMISTRY

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Alanine Aminotransferase (ALT or SGPT)Initial Grouping by Reagent and Instrument

Abbott no P5P & Abbott Architectc, ci, i

1 116.0 -174.0

P 145.1 4.5 51.0 - 77.0 P 63.8 2.7 66.0 - 99.0 P 82.2 2.9 146.0 -219.0

P 182.5 4.3 164.0 -245.0

P 204.4 5.2 17

Alfa Wassermann & Alfa WasserACE/Centr/Alera

2105.0 -158.0

P 131.9 5.1 49.0 - 73.0 P 60.9 3.6 60.0 - 91.0 P 75.5 3.4129.0 -194.0

P 161.8 6.1148.0 -222.0

P 185.3 6.9 80

Beckman no P5P & BeckmanSynchron CX4/CX5

3 107.0 -161.0

P 133.8 2.8 48.0 - 71.0 P 59.6 1.4 61.0 - 91.0 P 76.0 2.1 134.0 -201.0

P 167.4 3.4 151.0 -227.0

P 189.1 4.2 19

Beckman no P5P & BeckmanSynchron CX3/7/9/L

4106.0 -160.0

P 133.0 3.9 47.0 - 71.0 P 59.0 2.1 60.0 - 90.0 P 75.4 2.3133.0 -199.0

P 166.1 4.3150.0 -225.0

P 187.1 4.7 29

Beckman no P5P & BeckmanUnicel DXC series

5 112.0 -168.0

P 139.7 2.9 50.0 - 75.0 P 62.6 1.6 64.0 - 96.0 P 79.6 1.9 140.0 -210.0

P 174.7 3.4 157.0 -235.0

P 196.2 4.2 67

Clinical Data ATAC & VitalDiagnostics ATAC 8000

6110.0 -165.0

P 137.2 8.3 48.0 - 72.0 P 60.2 3.7 61.0 - 92.0 P 76.6 4.5135.0 -203.0

P 169.2 9.8153.0 -230.0

P 191.6 13.1 19

Clinical Data Envoy & VitalDiagnostics Envoy 500

7 120.0 -179.0

P 149.5 3.7 52.0 - 78.0 P 64.9 1.8 67.0 -101.0

P 84.2 2.5 149.0 -224.0

P 186.4 4.8 168.0 -252.0

P 209.8 5.4 13

DCL/Genzyme & Roche CobasMira series

8104.0 -156.0

P 130.2 3.4 47.0 - 70.0 P 58.2 1.3 59.0 - 89.0 P 74.1 1.8131.0 -197.0

P 164.1 4.6147.0 -221.0

P 184.0 3.8 10

Horriba ABX & Horiba ABX Pentra400

9 123.0 -184.0

P 153.7 4.4 54.0 - 81.0 P 67.4 2.3 68.0 -102.0

P 85.1 3.0 152.0 -228.0

P 190.0 6.1 172.0 -259.0

P 215.5 5.8 13

J&J Vitros & J&J Vitros not DT orECi

10120.0 -180.0

P 149.9 3.5 54.0 - 81.0 P 67.3 3.067.0 -100.0

P 83.7 3.4148.0 -223.0

P 185.6 3.9170.0 -255.0

P 212.6 4.6 81

J&J Vitros & J&J Vitros 5,1 FS 11 120.0 -180.0

P 150.4 4.1 56.0 - 84.0 P 70.3 4.3 69.0 -103.0

P 86.1 3.8 150.0 -226.0

P 188.1 4.9 170.0 -255.0

P 212.5 5.6 17

Beckman Olympus & Beck Oly AU400/600/5400

12102.0 -153.0

P 127.8 5.2 44.0 - 67.0 P 55.5 2.6 57.0 - 85.0 P 71.2 2.9127.0 -191.0

P 159.0 6.3143.0 -215.0

P 179.3 7.0 46

Roche Cobas & Roche Cobas6000

13 117.0 -175.0

P 145.7 3.7 50.0 - 76.0 P 63.1 1.9 65.0 - 97.0 P 80.7 2.2 145.0 -217.0

P 181.2 4.7 164.0 -245.0

P 204.4 5.3 10

Roche Cobas & Roche CobasIntegra

14116.0 -174.0

P 145.0 2.6 50.0 - 75.0 P 62.7 1.2 64.0 - 96.0 P 80.1 1.3144.0 -216.0

P 179.6 2.5163.0 -245.0

P 204.1 3.5 27

SDI Biomed & SDI CA240, 480 15 97.0 -146.0

P 121.6 10.5 45.0 - 67.0 P 55.8 4.8 58.0 - 86.0 P 72.1 6.4 123.0 -185.0

P 153.9 10.8 135.0 -202.0

P 168.4 16.4 17

Siemens no P5P & Siemens Adviaseries

16118.0 -177.0

P 147.3 4.0 52.0 - 78.0 P 65.2 3.067.0 -100.0

P 83.2 3.4146.0 -219.0

P 182.4 6.2164.0 -246.0

P 205.2 8.6 17

Siemens Dimension & SiemensDimension series

17 126.0 -188.0

P 157.0 3.9 62.0 - 92.0 P 76.9 2.7 76.0 -115.0

P 95.6 3.2 155.0 -233.0

P 193.8 5.7 173.0 -259.0

P 215.9 5.3 80

Page 2: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Siemens Dimension & SiemensDimension EXL

18 124.0 -186.0

P 155.1 2.5 61.0 - 91.0 P 76.0 2.3 76.0 -114.0

P 95.4 2.1 155.0 -232.0

P 193.4 4.0 172.0 -258.0

P 215.2 3.1 17

Siemens Dimension & SiemensDimension Rxl

19124.0 -186.0

P 155.2 3.1 61.0 - 91.0 P 76.2 2.175.0 -113.0

P 94.3 2.8153.0 -230.0

P 191.6 4.0171.0 -257.0

P 213.9 5.1 19

Siemens Dimension & SiemensDimension Xpand

20 126.0 -189.0

P 157.4 3.4 62.0 - 93.0 P 77.4 2.1 77.0 -115.0

P 95.7 2.4 155.0 -233.0

P 194.2 4.2 173.0 -260.0

P 216.7 4.9 93

Carolina & Beckman SynchronCX3/7/9/L

21 112.0 -168.0

P 139.6 5.4 49.0 - 73.0 P 61.2 1.9 63.0 - 95.0 P 78.8 2.1 138.0 -207.0

P 172.3 9.8 158.0 -238.0

P 197.9 5.6 16

Initial Grouping by Reagent

Abbott no P5P 22 116.0 -174.0

P 145.2 5.1 51.0 - 77.0 P 63.8 2.8 66.0 - 99.0 P 82.2 3.2 146.0 -220.0

P 183.0 4.1 164.0 -246.0

P 204.6 5.6 22

Alfa Wassermann 23106.0 -158.0

P 131.9 5.1 49.0 - 73.0 P 60.8 3.6 60.0 - 91.0 P 75.4 3.4129.0 -194.0

P 161.8 6.0148.0 -222.0

P 185.2 6.9 81

Beckman no P5P 24 110.0 -165.0

P 137.3 4.5 49.0 - 74.0 P 61.3 2.4 62.0 - 94.0 P 78.1 2.9 137.0 -206.0

P 171.5 5.6 154.0 -232.0

P 192.9 6.2 123

Clinical Data ATAC 25111.0 -167.0

P 138.9 10.8 48.0 - 73.0 P 60.5 3.9 62.0 - 92.0 P 77.0 4.7136.0 -204.0

P 170.0 10.2154.0 -231.0

P 192.6 13.4 20

Clinical Data Envoy 26 120.0 -179.0

P 149.4 3.5 52.0 - 78.0 P 65.1 1.8 68.0 -101.0

P 84.4 2.6 149.0 -224.0

P 186.4 4.7 168.0 -252.0

P 209.7 5.2 15

Cliniqa/RAI/King Diag 27110.0 -165.0

P 137.8 9.1 48.0 - 72.0 P 60.3 2.3 62.0 - 93.0 P 77.3 3.2137.0 -206.0

P 171.5 11.3157.0 -236.0

P 196.3 14.4 10

DCL/Genzyme 28 105.0 -157.0

P 130.7 5.6 46.0 - 69.0 P 57.4 2.3 59.0 - 89.0 P 74.0 3.0 132.0 -198.0

P 164.9 6.4 148.0 -221.0

P 184.6 6.8 21

Horriba ABX 29123.0 -184.0

P 153.7 4.4 54.0 - 81.0 P 67.4 2.368.0 -102.0

P 85.1 3.0152.0 -228.0

P 190.0 6.1172.0 -259.0

P 215.5 5.8 13

J&J Vitros 30 120.0 -180.0

P 150.1 3.6 54.0 - 82.0 P 68.0 3.5 67.0 -101.0

P 84.3 3.5 149.0 -223.0

P 185.9 4.2 170.0 -255.0

P 212.5 4.7 106

Beckman Olympus 31 102.0 -153.0

P 127.8 5.1 44.0 - 67.0 P 55.4 2.5 57.0 - 85.0 P 71.2 2.9 127.0 -191.0

P 158.9 6.2 143.0 -215.0

P 179.2 6.9 49

Pointe Sci 37 deg 32 119.0 -178.0

P 148.4 7.3 52.0 - 78.0 P 65.0 3.7 66.0 - 99.0 P 82.2 5.1 147.0 -221.0

P 184.2 10.5 166.0 -249.0

P 207.6 12.4 21

Roche Cobas 33 115.0 -173.0

P 144.3 3.8 50.0 - 75.0 P 62.5 1.6 64.0 - 96.0 P 80.0 1.9 143.0 -215.0

P 179.1 4.5 162.0 -244.0

P 203.1 5.6 46

Roche/Hitachi no P5P 34 116.0 -174.0

P 144.8 7.6 51.0 - 77.0 P 63.8 3.0 65.0 - 98.0 P 81.7 3.9 145.0 -217.0

P 181.1 8.9 163.0 -245.0

P 203.8 10.4 19

SDI Biomed 35 97.0 -146.0

P 121.6 10.5 45.0 - 67.0 P 55.8 4.8 58.0 - 86.0 P 72.1 6.4 123.0 -185.0

P 153.9 10.8 135.0 -202.0

P 168.4 16.4 17

Siemens no P5P 36 117.0 -176.0

P 146.7 4.6 52.0 - 78.0 P 65.0 3.1 66.0 - 99.0 P 82.9 3.5 145.0 -218.0

P 181.8 6.5 164.0 -245.0

P 204.6 8.7 18

Siemens Dimension 37 126.0 -188.0

P 156.9 3.6 62.0 - 92.0 P 77.0 2.4 76.0 -115.0

P 95.5 2.8 155.0 -233.0

P 193.8 4.8 173.0 -259.0

P 216.0 5.0 209

Thermo Scientific Infinity 38 104.0 -156.0

P 129.6 5.6 45.0 - 68.0 P 56.5 2.3 58.0 - 87.0 P 72.5 4.0 130.0 -195.0

P 162.4 8.1 145.0 -218.0

P 181.6 7.9 11

Carolina 39 112.0 -168.0

P 139.8 6.1 49.0 - 73.0 P 61.0 2.1 63.0 - 95.0 P 79.0 2.5 139.0 -209.0

P 173.8 10.2 158.0 -236.0

P 197.0 6.2 24

Initial Grouping by Sensitivity or Principle

Page 3: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Low moderate recovery meths 40 106.0 -159.0

P 132.6 8.8 48.0 - 72.0 P 60.2 4.5 60.0 - 91.0 P 75.5 4.6 131.0 -197.0

P 163.9 14.2 148.0 -222.0

P 185.2 17.6 22

Moderate recovery methods 41107.0 -160.0

P 133.2 7.7 48.0 - 72.0 P 59.7 4.0 61.0 - 91.0 P 75.7 4.6132.0 -199.0

P 165.6 9.5150.0 -224.0

P 187.0 11.1 291

High moderate recovery meth 42 115.0 -173.0

P 143.9 8.2 51.0 - 76.0 P 63.2 4.2 65.0 - 97.0 P 80.8 5.1 143.0 -215.0

P 179.0 9.7 161.0 -242.0

P 201.7 11.2 199

High recovery methods 43 123.0 -184.0

P 153.6 6.3 58.0 - 87.0 P 72.7 6.0 72.0 -109.0

P 90.5 6.8 152.0 -228.0

P 190.0 7.9 171.0 -256.0

P 213.7 7.3 359

Total Population

Whole Population 44 115.0 -173.0

P 144.0 12.0 53.0 - 79.0 P 65.9 7.8 66.0 -100.0

P 83.0 8.9 143.0 -214.0

P 178.6 14.6 161.0 -242.0

P 201.4 15.9 896

Alkaline PhosphataseInitial Grouping by Reagent and Instrument

Abbott & Abbott Architect c, ci, i 1 175.0 -326.0

P 250.4 10.6 63.0 -116.0

P 89.5 3.9 77.0 -143.0

P 110.3 4.6 203.0 -376.0

P 289.4 11.6 241.0 -449.0

P 345.0 14.9 19

Alfa Wassermann & Alfa WasserACE/Centr/Alera

2 169.0 -314.0

P 241.7 14.4 60.0 -111.0

P 85.3 5.5 72.0 -135.0

P 103.5 6.2 195.0 -362.0

P 278.3 15.9 236.0 -437.0

P 336.5 19.0 78

Beckman & Beckman SynchronCX4/CX5

3 147.0 -273.0

P 210.1 8.6 53.0 - 98.0 P 75.5 2.9 65.0 -121.0

P 93.4 3.6 173.0 -321.0

P 247.1 11.4 204.0 -379.0

P 291.5 11.4 19

Beckman & Beckman SynchronCX3/7/9/L

4 148.0 -275.0

P 211.3 12.0 53.0 - 99.0 P 76.1 4.8 66.0 -122.0

P 93.9 5.4 174.0 -322.0

P 247.9 13.8 207.0 -384.0

P 295.0 15.6 28

Beckman & Beckman Unicel DXCseries

5 153.0 -285.0

P 218.9 11.3 54.0 -101.0

P 77.8 4.1 68.0 -126.0

P 96.6 4.9 179.0 -333.0

P 256.1 12.3 213.0 -396.0

P 304.4 13.4 69

Carolina & Beckman SynchronCX3/7/9/L

6153.0 -284.0

P 218.2 17.655.0 -102.0

P 78.2 6.467.0 -125.0

P 96.3 7.8176.0 -326.0

P 251.0 23.2212.0 -394.0

P 303.1 24.8 18

Clinical Data ATAC & VitalDiagnostics ATAC 8000

7 158.0 -293.0

P 225.7 10.9 59.0 -109.0

P 83.9 5.8 72.0 -134.0

P 102.9 8.8 186.0 -345.0

P 265.1 18.3 221.0 -410.0

P 315.3 19.9 19

Clinical Data Envoy & VitalDiagnostics Envoy 500

8159.0 -295.0

P 227.1 8.359.0 -110.0

P 84.5 4.071.0 -132.0

P 101.7 6.5188.0 -349.0

P 268.8 9.7224.0 -415.0

P 319.4 11.2 13

DCL/Genzyme & Roche CobasMira series

9 154.0 -286.0

P 220.4 14.9 52.0 - 97.0 P 74.7 6.1 64.0 -119.0

P 91.9 6.8 176.0 -327.0

P 251.3 15.9 212.0 -394.0

P 303.4 19.0 11

Horriba ABX & Horiba ABX Pentra400

10174.0 -323.0

P 248.5 9.962.0 -115.0

P 88.7 4.577.0 -144.0

P 110.5 4.8205.0 -380.0

P 292.2 11.4243.0 -451.0

P 346.5 12.4 13

J&J Vitros & J&J Vitros not DT orECi

11 122.0 -227.0

P 174.6 9.0 49.0 - 91.0 P 69.8 3.7 60.0 -112.0

P 86.3 4.6 140.0 -260.0

P 200.2 11.0 163.0 -303.0

P 233.2 11.4 79

J&J Vitros & J&J Vitros 5,1 FS 12127.0 -236.0

P 181.5 7.6 52.0 - 96.0 P 73.6 3.363.0 -118.0

P 90.6 3.9147.0 -273.0

P 209.7 8.4168.0 -312.0

P 240.2 9.0 17

Beckman Olym DEA/converted &Beck Oly AU 400/600/5400

13 149.0 -277.0

P 213.0 13.3 53.0 - 99.0 P 75.9 4.9 65.0 -121.0

P 92.9 5.7 172.0 -319.0

P 245.3 15.6 205.0 -382.0

P 293.6 18.7 28

Beckman Olympus no DEA &Beck Oly AU 400/600/5400

14149.0 -277.0

P 212.9 13.0 53.0 - 99.0 P 76.1 4.965.0 -121.0

P 93.1 5.3171.0 -317.0

P 244.1 16.2205.0 -381.0

P 292.9 18.7 19

Roche IFCC Gen. 2 & RocheCobas 6000

15 162.0 -301.0

P 231.7 8.3 57.0 -105.0

P 80.8 2.8 70.0 -130.0

P 100.0 3.5 188.0 -349.0

P 268.1 9.6 224.0 -415.0

P 319.6 11.4 10

Roche IFCC Gen. 2 & Roche 161.0 - 56.0 - 69.0 - 185.0 - 223.0 -

Page 4: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Cobas Integra 16 298.0 P 229.6 9.0 103.0 P 79.5 3.1 128.0 P 98.3 3.4 344.0 P 264.7 8.6 414.0 P 318.5 10.8 28

SDI Biomed & SDI CA240, 480 17 160.0 -297.0

P 228.2 15.0 57.0 -107.0

P 82.1 5.7 69.0 -128.0

P 98.2 7.3 180.0 -334.0

P 256.6 21.5 219.0 -408.0

P 313.5 24.5 17

Siemens & Siemens Advia series 18 168.0 -312.0

P 240.1 12.8 60.0 -112.0

P 86.2 4.7 74.0 -138.0

P 106.4 6.0 196.0 -365.0

P 280.5 12.8 234.0 -434.0

P 333.9 15.7 18

Siemens Dimension & SiemensDimension series

19 178.0 -331.0

P 254.6 14.4 65.0 -121.0

P 93.4 8.2 79.0 -148.0

P 113.6 7.9 207.0 -385.0

P 296.0 15.3 245.0 -455.0

P 350.2 17.5 80

Siemens Dimension & SiemensDimension EXL

20 187.0 -348.0

P 267.8 14.6 70.0 -130.0

P 99.8 5.4 85.0 -158.0

P 121.3 6.1 217.0 -404.0

P 310.7 14.2 258.0 -480.0

P 368.9 13.1 18

Siemens Dimension & SiemensDimension Rxl

21 183.0 -340.0

P 261.3 14.6 67.0 -125.0

P 95.8 7.0 81.0 -150.0

P 115.5 8.9 214.0 -398.0

P 306.4 10.3 254.0 -471.0

P 362.4 12.2 19

Siemens Dimension & SiemensDimension Xpand

22 174.0 -323.0

P 248.4 11.3 63.0 -118.0

P 90.4 5.9 77.0 -144.0

P 110.6 7.1 205.0 -380.0

P 292.4 13.3 243.0 -452.0

P 347.4 16.3 98

Initial Grouping by Reagent

Abbott 23175.0 -325.0

P 250.2 11.863.0 -117.0

P 89.7 3.777.0 -144.0

P 110.5 4.6202.0 -375.0

P 288.8 13.6242.0 -449.0

P 345.4 13.9 22

Alfa Wassermann 24 169.0 -314.0

P 241.7 14.4 60.0 -111.0

P 85.3 5.5 72.0 -135.0

P 103.5 6.2 195.0 -362.0

P 278.6 15.9 236.0 -438.0

P 336.7 18.9 79

Beckman 25151.0 -281.0

P 216.2 11.654.0 -100.0

P 77.2 4.267.0 -124.0

P 95.5 5.0177.0 -329.0

P 252.9 12.9210.0 -391.0

P 300.4 14.4 125

Carolina 26 151.0 -280.0

P 215.7 17.1 54.0 -100.0

P 77.3 6.0 67.0 -124.0

P 95.3 7.7 174.0 -324.0

P 248.9 20.6 209.0 -388.0

P 298.7 23.8 29

Clinical Data ATAC 27159.0 -294.0

P 226.5 11.159.0 -109.0

P 83.6 5.872.0 -133.0

P 102.6 8.7185.0 -344.0

P 264.6 18.0221.0 -410.0

P 315.0 19.4 20

Clinical Data Envoy 28 158.0 -294.0

P 226.2 8.7 59.0 -109.0

P 83.7 4.2 70.0 -131.0

P 100.5 6.9 186.0 -346.0

P 266.2 11.2 221.0 -411.0

P 316.3 13.2 15

Cliniqa/RAI/King Diag 29152.0 -283.0

P 217.6 21.6 53.0 - 98.0 P 75.7 7.667.0 -124.0

P 95.2 8.5175.0 -326.0

P 250.5 25.8213.0 -396.0

P 304.4 34.9 10

DCL/Genzyme 30 167.0 -310.0

P 238.3 26.7 57.0 -106.0

P 81.8 10.4 71.0 -132.0

P 101.3 12.4 192.0 -357.0

P 274.6 32.2 231.0 -429.0

P 329.7 37.8 26

Horriba ABX 31174.0 -323.0

P 248.5 9.962.0 -115.0

P 88.7 4.577.0 -144.0

P 110.5 4.8205.0 -380.0

P 292.2 11.4243.0 -451.0

P 346.5 12.4 13

J&J Vitros 32 123.0 -229.0

P 176.0 9.0 49.0 - 91.0 P 70.4 3.9 61.0 -113.0

P 87.2 4.9 142.0 -263.0

P 202.3 11.2 164.0 -305.0

P 234.7 11.4 102

Beckman Olym DEA/converted 33149.0 -278.0

P 213.6 13.5 53.0 - 99.0 P 76.1 4.965.0 -121.0

P 93.1 5.7172.0 -320.0

P 245.9 15.6206.0 -383.0

P 294.4 18.9 29

Beckman Olympus no DEA 34 151.0 -280.0

P 215.4 15.7 54.0 -100.0

P 77.0 5.9 66.0 -123.0

P 94.3 6.6 173.0 -321.0

P 246.5 17.7 207.0 -384.0

P 295.7 20.2 22

Pointe Sci 35173.0 -321.0

P 247.2 25.861.0 -114.0

P 87.5 10.675.0 -138.0

P 106.5 12.0196.0 -363.0

P 279.4 28.8238.0 -442.0

P 339.7 32.2 21

Roche/Hit 9xx/Mod AMP IFCC 36 158.0 -293.0

P 225.2 9.9 56.0 -103.0

P 79.5 3.0 69.0 -127.0

P 97.9 3.3 183.0 -339.0

P 260.8 10.0 218.0 -405.0

P 311.5 11.4 13

Roche IFCC Gen. 2 37161.0 -298.0

P 229.5 10.456.0 -104.0

P 79.7 3.469.0 -128.0

P 98.5 3.9186.0 -345.0

P 265.0 10.4223.0 -413.0

P 317.9 12.8 47

SDI Biomed 38 160.0 -297.0

P 228.2 15.0 57.0 -107.0

P 82.1 5.7 69.0 -128.0

P 98.2 7.3 180.0 -334.0

P 256.6 21.5 219.0 -408.0

P 313.5 24.5 17

Page 5: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Siemens 39 168.0 -312.0

P 240.1 12.8 60.0 -112.0

P 86.2 4.7 74.0 -138.0

P 106.4 6.0 196.0 -365.0

P 280.5 12.8 234.0 -434.0

P 333.9 15.7 18

Siemens Dimension 40177.0 -330.0

P 253.5 14.365.0 -121.0

P 92.8 7.479.0 -147.0

P 113.0 8.0208.0 -385.0

P 296.5 15.0246.0 -457.0

P 351.6 17.4 215

Initial Grouping by Sensitivity or Principle

Low moderate recovery meths 41 151.0 -281.0

P 216.2 14.3 54.0 -101.0

P 77.4 4.9 67.0 -124.0

P 95.3 5.9 176.0 -327.0

P 251.6 16.4 210.0 -390.0

P 299.9 19.1 148

Moderate recovery methods 42139.0 -258.0

P 198.6 31.2 53.0 - 98.0 P 75.4 8.665.0 -121.0

P 93.3 10.4161.0 -299.0

P 229.8 38.2189.0 -351.0

P 270.1 47.7 172

High moderate recovery meth 43 163.0 -303.0

P 233.3 22.5 59.0 -110.0

P 84.5 8.8 72.0 -134.0

P 103.4 10.5 189.0 -352.0

P 270.6 26.6 227.0 -422.0

P 324.3 31.6 117

High recovery methods 44163.0 -303.0

P 233.2 18.257.0 -106.0

P 81.7 6.870.0 -130.0

P 100.2 7.8188.0 -350.0

P 268.9 21.0226.0 -420.0

P 323.3 25.5 204

Very high recovery methods 45 177.0 -329.0

P 253.4 14.4 65.0 -121.0

P 92.7 7.4 79.0 -147.0

P 113.0 8.0 208.0 -385.0

P 296.5 15.0 246.0 -457.0

P 351.6 17.4 219

Total Population

Whole Population 46 160.0 -297.0

P 228.4 28.1 58.0 -107.0

P 82.7 9.5 71.0 -132.0

P 101.6 11.3 186.0 -345.0

P 265.4 33.6 221.0 -411.0

P 316.2 40.8 874

AmylaseInitial Grouping by Reagent and Instrument

Abbott Aeroset/Architect & AbbottArchitect c, ci, i

1 246.0 -456.0

P 351.1 10.7 105.0 -195.0

P 149.7 4.7 121.0 -225.0

P 173.1 5.4 278.0 -517.0

P 397.6 12.3 334.0 -620.0

P 476.8 15.0 16

Alfa Wassermann & Alfa WasserACE/Centr/Alera

2 244.0 -454.0

P 349.0 20.2 102.0 -189.0

P 145.4 9.8 120.0 -222.0

P 170.9 13.3 282.0 -523.0

P 402.2 21.6 337.0 -626.0

P 481.5 23.8 18

Beckman AMY & BeckmanSynchron CX4/CX5

3 101.0 -188.0

P 144.7 6.4 59.0 -109.0

P 83.7 5.2 68.0 -126.0

P 96.7 4.4 121.0 -224.0

P 172.5 6.1 131.0 -244.0

P 187.7 8.0 15

Beckman AMY & BeckmanSynchron CX3/7/9/L

4 102.0 -189.0

P 145.5 4.5 59.0 -110.0

P 84.3 4.4 69.0 -128.0

P 98.5 4.2 121.0 -225.0

P 173.3 5.1 134.0 -248.0

P 191.1 6.5 18

Beckman AMY & Beckman UnicelDXC series

5 105.0 -195.0

P 150.3 5.4 61.0 -114.0

P 87.8 5.1 71.0 -132.0

P 101.5 5.3 125.0 -233.0

P 179.2 6.2 138.0 -256.0

P 196.6 6.6 60

Carolina & Beckman SynchronCX3/7/9/L

6 382.0 -709.0

P 545.2 21.9 168.0 -312.0

P 239.9 9.1 196.0 -363.0

P 279.4 10.1 433.0 -803.0

P 618.1 18.1 512.0 -951.0

P 731.7 28.0 15

J&J Vitros & J&J Vitros not DT orECi

7 88.0 -163.0

P 125.8 5.1 38.0 - 70.0 P 53.8 4.2 44.0 - 81.0 P 62.5 4.4 93.0 -173.0

P 133.3 5.6 118.0 -220.0

P 168.9 7.1 57

J&J Vitros & J&J Vitros 5,1 FS 8 89.0 -164.0

P 126.5 4.8 38.0 - 71.0 P 54.4 4.1 45.0 - 85.0 P 65.0 3.7 97.0 -179.0

P 138.0 7.0 118.0 -219.0

P 168.1 5.7 14

Beckman Olympus & Beck Oly AU400/600/5400

9 194.0 -361.0

P 277.7 13.7 79.0 -146.0

P 112.6 6.0 91.0 -168.0

P 129.5 5.8 216.0 -402.0

P 309.3 15.5 263.0 -488.0

P 375.6 18.1 36

Roche Cobas alpha-amylase &Roche Cobas Integra

10 202.0 -374.0

P 288.0 4.8 87.0 -161.0

P 123.8 3.4 101.0 -187.0

P 143.8 2.7 229.0 -425.0

P 327.3 5.7 273.0 -508.0

P 390.5 5.5 22

Siemens & Siemens Advia series 11 209.0 -388.0

P 298.2 12.4 89.0 -165.0

P 126.6 5.4 104.0 -192.0

P 148.0 6.1 239.0 -443.0

P 341.1 14.8 283.0 -525.0

P 403.9 17.1 14

Siemens Dimension & SiemensDimension series

12 268.0 -499.0

P 383.5 7.5 107.0 -198.0

P 152.4 3.4 124.0 -231.0

P 177.4 3.7 301.0 -559.0

P 429.8 9.4 368.0 -683.0

P 525.3 10.6 63

Page 6: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Siemens Dimension & SiemensDimension EXL

13 269.0 -501.0

P 385.0 5.0 107.0 -199.0

P 153.0 1.9 124.0 -231.0

P 177.6 3.0 302.0 -560.0

P 430.7 6.2 368.0 -684.0

P 525.8 8.4 18

Siemens Dimension & SiemensDimension Rxl

14264.0 -489.0

P 376.4 7.1106.0 -197.0

P 151.5 2.6123.0 -228.0

P 175.1 3.8297.0 -552.0

P 424.9 8.9364.0 -676.0

P 519.9 13.8 16

Siemens Dimension & SiemensDimension Xpand

15 268.0 -498.0

P 383.0 7.5 107.0 -198.0

P 152.6 3.3 124.0 -230.0

P 177.2 3.8 302.0 -560.0

P 431.0 7.9 370.0 -687.0

P 528.4 10.4 69

Initial Grouping by Reagent

Abbott Aeroset/Architect 16246.0 -457.0

P 351.4 10.4105.0 -195.0

P 149.9 4.6121.0 -225.0

P 173.3 5.3279.0 -518.0

P 398.1 12.1334.0 -620.0

P 477.2 14.6 17

Alfa Wassermann 17 243.0 -452.0

P 347.6 20.4 102.0 -189.0

P 145.6 9.5 120.0 -222.0

P 170.8 13.0 282.0 -523.0

P 402.5 21.0 336.0 -625.0

P 480.6 23.5 19

Beckman AMY 18104.0 -193.0

P 148.3 5.860.0 -112.0

P 86.3 5.170.0 -130.0

P 100.0 5.2124.0 -230.0

P 176.8 6.6136.0 -252.0

P 194.1 7.6 99

Carolina 19 378.0 -703.0

P 540.4 23.8 167.0 -310.0

P 238.6 9.8 194.0 -361.0

P 277.6 11.1 432.0 -802.0

P 616.7 18.0 509.0 -945.0

P 727.1 28.2 21

DCL/Genzyme 20206.0 -383.0

P 294.5 21.083.0 -155.0

P 119.1 11.9100.0 -186.0

P 143.3 14.5237.0 -440.0

P 338.4 32.4285.0 -529.0

P 406.8 32.2 11

J&J Vitros 21 88.0 -164.0

P 126.2 5.4 38.0 - 70.0 P 53.8 4.1 44.0 - 82.0 P 62.7 4.6 94.0 -174.0

P 134.0 6.5 118.0 -220.0

P 169.2 7.4 78

Beckman Olympus 22196.0 -364.0

P 280.3 15.679.0 -147.0

P 113.2 6.291.0 -170.0

P 130.6 6.8218.0 -406.0

P 312.0 17.2265.0 -492.0

P 378.3 19.3 40

Roche Cobas alpha-amylase 23 202.0 -376.0

P 289.0 5.8 87.0 -161.0

P 124.0 3.2 101.0 -188.0

P 144.7 3.0 230.0 -428.0

P 329.0 6.9 274.0 -508.0

P 391.1 5.6 34

Roche/Hitachi alpha-amylase 24200.0 -371.0

P 285.2 7.485.0 -159.0

P 122.1 3.9100.0 -186.0

P 143.3 4.6228.0 -424.0

P 326.0 7.1271.0 -503.0

P 386.6 7.8 16

Siemens 25 209.0 -388.0

P 298.2 12.4 89.0 -165.0

P 126.6 5.4 104.0 -192.0

P 148.0 6.1 239.0 -443.0

P 341.1 14.8 283.0 -525.0

P 403.9 17.1 14

Siemens Dimension 26 268.0 -498.0

P 382.8 7.5 107.0 -198.0

P 152.5 3.2 124.0 -230.0

P 177.1 3.7 301.0 -559.0

P 429.9 8.6 368.0 -684.0

P 526.1 10.8 166

Initial Grouping by Sensitivity or Principle

Extremely low recovery meth 2799.0 -183.0

P 140.7 18.1 51.0 - 95.0 P 72.9 17.459.0 -110.0

P 84.6 20.2112.0 -209.0

P 160.5 26.8130.0 -242.0

P 185.9 22.1 182

Low moderate recovery meth 28 200.0 -371.0

P 285.5 16.9 82.0 -152.0

P 117.0 8.5 95.0 -176.0

P 135.5 10.3 224.0 -417.0

P 320.6 21.4 270.0 -502.0

P 386.1 22.1 56

Moderate recovery methods 29210.0 -391.0

P 300.7 30.988.0 -163.0

P 125.7 12.9104.0 -192.0

P 148.0 14.9241.0 -447.0

P 344.1 34.6289.0 -536.0

P 412.5 42.9 50

High moderate recovery meth 30 274.0 -508.0

P 390.8 50.6 111.0 -206.0

P 158.8 25.3 129.0 -240.0

P 184.7 29.4 308.0 -573.0

P 440.5 57.2 374.0 -695.0

P 534.5 64.7 235

All other methods 31205.0 -381.0

P 293.2 24.788.0 -164.0

P 125.9 11.6103.0 -191.0

P 147.0 13.6234.0 -434.0

P 333.7 27.5278.0 -516.0

P 397.0 34.2 35

Total Population

Whole Population 32 230.0 -428.0

P 328.9 47.7 90.0 -167.0

P 128.3 25.6 104.0 -193.0

P 148.8 30.2 262.0 -486.0

P 374.0 53.2 301.0 -558.0

P 429.4 62.3 578

Aspartate Aminotransferase (AST or SGOT)

Page 7: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Initial Grouping by Reagent and Instrument

Abbott no P5P & Abbott Architectc, ci, i

1 97.0 -146.0

P 121.3 3.6 41.0 - 62.0 P 51.6 1.7 52.0 - 78.0 P 64.9 2.9 118.0 -177.0

P 147.6 4.8 138.0 -207.0

P 172.2 5.1 17

Alfa Wassermann & Alfa WasserACE/Centr/Alera

299.0 -149.0

P 124.0 6.3 42.0 - 64.0 P 53.0 3.3 52.0 - 78.0 P 65.3 4.0118.0 -177.0

P 147.9 7.3140.0 -210.0

P 174.8 7.8 79

Beckman no P5P & BeckmanSynchron CX4/CX5

3 92.0 -138.0

P 115.2 5.6 39.0 - 58.0 P 48.4 3.0 49.0 - 73.0 P 60.9 3.8 112.0 -168.0

P 140.2 7.0 131.0 -196.0

P 163.4 7.4 20

Beckman no P5P & BeckmanSynchron CX3/7/9/L

491.0 -136.0

P 113.5 6.3 38.0 - 57.0 P 47.9 2.8 47.0 - 71.0 P 59.4 4.1111.0 -166.0

P 138.3 7.3129.0 -193.0

P 161.2 8.1 28

Beckman no P5P & BeckmanUnicel DXC series

5 96.0 -144.0

P 120.0 4.8 41.0 - 61.0 P 51.2 2.4 51.0 - 76.0 P 63.5 2.8 116.0 -174.0

P 145.4 5.3 136.0 -203.0

P 169.4 5.9 68

Carolina & Beckman SynchronCX3/7/9/L

6102.0 -152.0

P 127.0 7.5 43.0 - 64.0 P 53.7 4.0 54.0 - 81.0 P 67.4 5.4125.0 -187.0

P 156.2 11.7144.0 -216.0

P 180.1 11.2 18

Clinical Data ATAC & VitalDiagnostics ATAC 8000

7 89.0 -133.0

P 110.7 9.8 39.0 - 58.0 P 48.2 5.6 46.0 - 70.0 P 57.9 6.6 105.0 -158.0

P 131.3 12.6 124.0 -186.0

P 155.3 14.5 19

Clinical Data Envoy & VitalDiagnostics Envoy 500

8101.0 -152.0

P 126.6 7.2 43.0 - 65.0 P 54.2 4.7 54.0 - 82.0 P 68.0 5.0123.0 -185.0

P 154.1 9.4143.0 -215.0

P 179.1 9.0 13

DCL/Genzyme & Roche CobasMira series

9 92.0 -137.0

P 114.5 6.5 39.0 - 58.0 P 48.7 3.0 48.0 - 72.0 P 59.9 4.2 111.0 -167.0

P 138.8 7.3 129.0 -193.0

P 160.7 9.3 10

Horriba ABX & Horiba ABX Pentra400

1099.0 -148.0

P 123.2 5.9 42.0 - 63.0 P 52.6 2.7 52.0 - 78.0 P 64.9 3.1118.0 -177.0

P 147.2 7.6138.0 -207.0

P 172.7 8.2 13

J&J Vitros & J&J Vitros not DT orECi

11 129.0 -194.0

P 161.6 5.8 61.0 - 92.0 P 76.4 3.4 77.0 -116.0

P 96.5 4.2 165.0 -247.0

P 205.8 7.3 183.0 -275.0

P 229.1 8.6 79

J&J Vitros & J&J Vitros 5,1 FS 12129.0 -193.0

P 161.1 7.0 60.0 - 90.0 P 75.4 3.277.0 -116.0

P 96.8 3.4163.0 -245.0

P 204.2 7.0178.0 -267.0

P 222.6 10.1 17

Beckman Olympus & Beck Oly AU400/600/5400

13 88.0 -132.0

P 110.2 5.8 37.0 - 56.0 P 46.7 2.8 47.0 - 70.0 P 58.2 3.3 106.0 -159.0

P 132.7 6.5 124.0 -186.0

P 154.8 7.7 47

Roche Cobas & Roche Cobas6000

14 100.0 -151.0

P 125.6 6.9 41.0 - 62.0 P 51.7 3.4 52.0 - 78.0 P 64.7 3.7 122.0 -183.0

P 152.2 6.8 141.0 -212.0

P 176.6 6.8 10

Roche Cobas & Roche CobasIntegra

15 100.0 -150.0

P 125.1 4.3 41.0 - 62.0 P 51.6 1.9 52.0 - 78.0 P 64.9 2.8 120.0 -180.0

P 150.1 5.8 140.0 -211.0

P 175.6 6.6 27

SDI Biomed & SDI CA240, 480 16 88.0 -131.0

P 109.5 5.5 36.0 - 55.0 P 45.6 2.8 49.0 - 73.0 P 60.8 4.5 108.0 -162.0

P 135.2 9.2 124.0 -186.0

P 155.2 9.6 16

Siemens no P5P & Siemens Adviaseries

17 104.0 -157.0

P 130.4 6.9 45.0 - 67.0 P 56.0 4.3 56.0 - 83.0 P 69.4 4.8 125.0 -187.0

P 156.2 8.3 146.0 -219.0

P 182.6 10.1 18

Siemens Dimension & SiemensDimension series

18 137.0 -205.0

P 170.9 4.9 65.0 - 97.0 P 81.0 2.9 83.0 -124.0

P 103.7 3.1 172.0 -259.0

P 215.4 6.7 191.0 -286.0

P 238.7 6.5 79

Siemens Dimension & SiemensDimension EXL

19 135.0 -203.0

P 169.1 3.2 64.0 - 96.0 P 80.2 1.7 82.0 -123.0

P 102.5 2.1 172.0 -258.0

P 215.2 4.7 190.0 -285.0

P 237.8 4.7 17

Siemens Dimension & SiemensDimension Rxl

20 135.0 -203.0

P 169.2 4.4 64.0 - 97.0 P 80.5 3.0 82.0 -123.0

P 102.8 3.1 171.0 -256.0

P 213.4 5.4 191.0 -286.0

P 238.2 6.2 19

Siemens Dimension & SiemensDimension Xpand

21 137.0 -205.0

P 171.1 3.8 65.0 - 97.0 P 81.2 3.1 83.0 -124.0

P 103.4 3.0 173.0 -259.0

P 216.0 4.9 192.0 -288.0

P 239.8 5.9 92

Initial Grouping by Reagent

Abbott no P5P 22 97.0 -146.0

P 121.6 4.6 41.0 - 62.0 P 51.8 2.2 52.0 - 78.0 P 65.2 3.3 119.0 -178.0

P 148.2 7.1 138.0 -207.0

P 172.8 6.4 20

Page 8: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Alfa Wassermann 23 99.0 -149.0

P 123.9 6.3 42.0 - 64.0 P 53.0 3.3 52.0 - 78.0 P 65.3 4.0 118.0 -177.0

P 147.8 7.3 140.0 -210.0

P 174.7 7.8 80

Beckman no P5P 2494.0 -141.0

P 117.5 6.1 40.0 - 60.0 P 49.9 3.0 50.0 - 74.0 P 62.1 3.8114.0 -171.0

P 142.5 7.0133.0 -200.0

P 166.3 7.6 124

Carolina 25 103.0 -155.0

P 129.2 10.2 43.0 - 65.0 P 53.9 4.6 54.0 - 82.0 P 68.1 6.1 126.0 -189.0

P 157.7 13.3 147.0 -220.0

P 183.3 13.7 29

Clinical Data ATAC 26 90.0 -134.0

P 112.0 11.1 39.0 - 58.0 P 48.4 5.5 47.0 - 70.0 P 58.2 6.6 106.0 -159.0

P 132.2 12.9 125.0 -188.0

P 156.3 14.9 20

Clinical Data Envoy 27 101.0 -152.0

P 126.3 6.8 43.0 - 65.0 P 54.3 4.3 55.0 - 82.0 P 68.3 4.8 123.0 -185.0

P 154.0 8.8 143.0 -214.0

P 178.7 8.5 15

Cliniqa/RAI/King Diag 28 94.0 -142.0

P 118.1 7.4 40.0 - 60.0 P 50.0 1.9 49.0 - 73.0 P 60.7 4.4 112.0 -168.0

P 140.4 7.3 131.0 -197.0

P 164.1 7.4 10

DCL/Genzyme 29 96.0 -144.0

P 120.0 12.1 40.0 - 61.0 P 50.6 4.8 51.0 - 76.0 P 63.4 6.3 117.0 -175.0

P 145.7 14.7 135.0 -203.0

P 169.4 18.0 25

Horriba ABX 30 99.0 -148.0

P 123.2 5.9 42.0 - 63.0 P 52.6 2.7 52.0 - 78.0 P 64.9 3.1 118.0 -177.0

P 147.2 7.6 138.0 -207.0

P 172.7 8.2 13

J&J Vitros 31 129.0 -194.0

P 161.7 6.2 61.0 - 92.0 P 76.3 3.4 77.0 -116.0

P 96.7 4.1 164.0 -247.0

P 205.6 7.1 182.0 -274.0

P 227.9 9.0 102

Beckman Olympus 32 88.0 -132.0

P 110.3 5.8 37.0 - 56.0 P 46.8 2.8 47.0 - 70.0 P 58.3 3.3 106.0 -159.0

P 132.9 6.6 124.0 -186.0

P 155.0 7.6 51

Pointe Sci 37 deg 33 108.0 -163.0

P 135.6 11.9 47.0 - 70.0 P 58.6 4.9 57.0 - 85.0 P 70.8 5.8 130.0 -195.0

P 162.6 14.2 153.0 -229.0

P 190.7 14.2 22

Roche Cobas 34 100.0 -150.0

P 125.3 5.4 41.0 - 62.0 P 51.9 2.5 52.0 - 78.0 P 64.9 3.2 120.0 -181.0

P 150.5 6.2 141.0 -211.0

P 176.1 6.8 47

Roche/Hitachi no P5P 35 99.0 -148.0

P 123.6 8.6 42.0 - 62.0 P 51.9 4.1 53.0 - 79.0 P 66.2 6.0 121.0 -181.0

P 151.0 11.4 139.0 -209.0

P 174.2 13.2 17

SDI Biomed 3687.0 -131.0

P 109.2 5.5 37.0 - 55.0 P 45.7 2.7 48.0 - 73.0 P 60.5 4.6107.0 -161.0

P 134.2 9.8124.0 -186.0

P 154.8 9.5 17

Siemens no P5P 37 104.0 -157.0

P 130.4 6.9 45.0 - 67.0 P 56.0 4.3 56.0 - 83.0 P 69.4 4.8 125.0 -187.0

P 156.2 8.3 146.0 -219.0

P 182.6 10.1 18

Siemens Dimension 38137.0 -205.0

P 170.7 4.3 65.0 - 97.0 P 81.0 2.983.0 -124.0

P 103.4 3.0172.0 -259.0

P 215.5 5.7191.0 -287.0

P 239.0 6.1 207

Sterling 39 125.0 -187.0

P 155.8 7.3 70.0 -105.0

P 87.1 6.9 77.0 -116.0

P 96.7 7.3 135.0 -202.0

P 168.4 14.6 156.0 -234.0

P 195.0 16.2 12

Initial Grouping by Sensitivity or Principle

Low recovery methods 40 91.0 -137.0

P 114.1 10.3 39.0 - 59.0 P 48.9 4.7 47.0 - 71.0 P 59.1 6.0 108.0 -162.0

P 134.9 11.9 127.0 -191.0

P 158.9 13.3 30

Low moderate recovery meth 41 95.0 -142.0

P 118.6 8.2 40.0 - 60.0 P 50.4 3.9 50.0 - 75.0 P 62.6 4.7 114.0 -172.0

P 143.0 9.4 134.0 -201.0

P 167.4 11.0 281

Moderate recovery methods 42 99.0 -149.0

P 123.8 11.4 42.0 - 62.0 P 52.0 5.3 52.0 - 78.0 P 65.4 6.5 120.0 -180.0

P 149.6 14.0 139.0 -209.0

P 174.3 15.8 170

High moderate recovery meth 43 107.0 -160.0

P 133.2 14.1 48.0 - 72.0 P 59.6 12.0 58.0 - 87.0 P 72.6 11.1 127.0 -190.0

P 158.3 14.3 148.0 -221.0

P 184.4 16.3 86

Very high recovery methods 44 134.0 -201.0

P 167.4 7.6 63.0 - 95.0 P 79.2 4.5 81.0 -121.0

P 101.0 5.7 169.0 -254.0

P 211.8 9.5 188.0 -282.0

P 234.9 10.6 318

Total Population

Page 9: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Whole Population 45 111.0 -166.0

P 138.3 24.0 49.0 - 73.0 P 60.7 13.5 60.0 - 90.0 P 74.9 17.0 136.0 -204.0

P 170.0 33.3 155.0 -233.0

P 194.3 33.3 894

CortisolInitial Grouping by Reagent and Instrument

Beckman Access luminometric &Beckman Access luminometer

1 7.0 - 12.0 P 9.2 0.4 12.0 - 20.0 P 15.6 0.8 16.0 - 26.0 P 20.7 1.1 15.0 - 24.0 P 19.6 1.1 9.0 - 14.0 P 11.6 0.8 10

Siemens Immulite & SiemensImmulite 2000

2 8.0 - 12.0 P 10.0 1.0 12.0 - 20.0 P 16.2 1.3 16.0 - 26.0 P 21.2 1.7 15.0 - 25.0 P 20.1 1.8 9.0 - 15.0 P 12.2 0.9 12

Initial Grouping by Reagent

Beckman Access luminometric 3 7.0 - 12.0 P 9.3 0.5 12.0 - 20.0 P 15.7 1.0 16.0 - 26.0 P 20.7 1.4 15.0 - 25.0 P 19.7 1.3 9.0 - 14.0 P 11.5 0.7 15

DiaSorin GammaCoat RIA 4 6.0 - 10.0 P 8.3 0.8 11.0 - 19.0 P 15.1 1.6 18.0 - 29.0 P 23.3 2.8 14.0 - 24.0 P 18.9 0.7 9.0 - 14.0 P 11.6 1.4 12

Roche Elecsys 5 6.0 - 10.0 P 8.1 0.3 11.0 - 18.0 P 14.5 0.8 15.0 - 25.0 P 19.7 1.0 14.0 - 23.0 P 18.7 1.3 8.0 - 13.0 P 10.3 0.8 11

Siemens Immulite 6 8.0 - 13.0 P 10.1 1.2 13.0 - 21.0 P 17.0 1.7 16.0 - 27.0 P 21.9 2.1 15.0 - 26.0 P 20.6 2.2 9.0 - 15.0 P 12.2 1.0 23

Initial Grouping by Sensitivity or Principle

Luminometric 7 7.0 - 12.0 P 9.4 1.2 12.0 - 20.0 P 16.0 1.7 16.0 - 26.0 P 20.9 2.0 15.0 - 25.0 P 19.8 2.0 9.0 - 14.0 P 11.5 1.2 55

Radiometric 8 6.0 - 11.0 P 8.6 0.9 11.0 - 19.0 P 14.8 1.6 17.0 - 28.0 P 22.2 2.8 14.0 - 24.0 P 19.1 1.0 9.0 - 14.0 P 11.4 1.3 20

Total Population

Whole Population 9 7.0 - 11.0 P 9.1 1.1 12.0 - 19.0 P 15.5 1.8 16.0 - 26.0 P 20.8 2.5 15.0 - 24.0 P 19.4 2.0 9.0 - 14.0 P 11.4 1.3 91

Creatine Kinase, Total (CK or CPK)Initial Grouping by Reagent and Instrument

Abbott & Abbott Architect c, ci, i 183.0 -154.0

P 118.8 2.8234.0 -434.0

P 333.8 6.1332.0 -616.0

P 473.8 9.0276.0 -512.0

P 393.9 5.7105.0 -195.0

P 150.1 2.6 17

Alfa Wassermann & Alfa WasserACE/Centr/Alera

2 75.0 -140.0

P 107.8 4.6 204.0 -379.0

P 291.7 10.5 288.0 -535.0

P 411.8 14.4 242.0 -450.0

P 346.0 15.1 95.0 -176.0

P 135.5 4.9 20

Beckman & Beckman SynchronCX4/CX5

383.0 -155.0

P 118.9 3.3233.0 -432.0

P 332.5 6.7325.0 -604.0

P 464.9 12.2270.0 -501.0

P 385.2 6.5102.0 -190.0

P 146.2 4.0 15

Beckman & Beckman SynchronCX3/7/9/L

4 82.0 -152.0

P 117.0 3.7 231.0 -428.0

P 329.5 12.3 325.0 -603.0

P 464.0 16.0 268.0 -497.0

P 382.5 13.6 101.0 -188.0

P 144.7 5.4 21

Beckman & Beckman Unicel DXCseries

586.0 -159.0

P 122.4 4.1242.0 -449.0

P 345.3 10.0340.0 -631.0

P 485.6 14.4280.0 -519.0

P 399.3 13.2107.0 -198.0

P 152.6 5.2 65

Carolina & Beckman SynchronCX3/7/9/L

6 70.0 -129.0

P 99.6 7.2 197.0 -366.0

P 281.4 19.6 280.0 -520.0

P 400.0 30.1 232.0 -430.0

P 330.9 25.1 87.0 -162.0

P 124.6 9.6 17

Clinical Data ATAC & VitalDiagnostics ATAC 8000

768.0 -126.0

P 97.1 11.3204.0 -379.0

P 291.3 10.2291.0 -540.0

P 415.1 18.7236.0 -439.0

P 337.4 20.188.0 -164.0

P 125.9 7.3 10

J&J Vitros & J&J Vitros not DT orECi

8 70.0 -131.0

P 100.6 7.6 195.0 -362.0

P 278.3 17.4 274.0 -509.0

P 391.9 24.2 237.0 -440.0

P 338.7 21.0 91.0 -170.0

P 130.4 8.2 54

J&J Vitros & J&J Vitros 5,1 FS 972.0 -134.0

P 103.1 5.8196.0 -364.0

P 280.0 14.6269.0 -500.0

P 384.4 20.3237.0 -440.0

P 338.3 16.492.0 -171.0

P 131.8 7.5 14

Beckman Olympus & Beck Oly AU400/600/5400

10 72.0 -134.0

P 103.3 4.4 205.0 -380.0

P 292.2 12.3 288.0 -535.0

P 411.9 16.9 238.0 -441.0

P 339.4 14.3 90.0 -168.0

P 129.1 5.9 40

Roche Cobas & Roche Cobas 81.0 - 225.0 - 322.0 - 266.0 - 100.0 -

Page 10: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

6000 11 151.0 P 115.9 4.7 419.0 P 322.1 13.4 599.0 P 460.4 17.2 494.0 P 380.1 13.1 186.0 P 142.8 8.9 10

Roche Cobas & Roche CobasIntegra

12 77.0 -143.0

P 109.7 4.3 215.0 -399.0

P 307.1 8.6 304.0 -564.0

P 433.9 10.1 252.0 -468.0

P 360.3 9.6 96.0 -179.0

P 137.4 4.6 23

Siemens Advia & Siemens Adviaseries

13 75.0 -140.0

P 107.5 5.1 214.0 -397.0

P 305.1 13.5 304.0 -564.0

P 434.2 19.2 252.0 -467.0

P 359.3 15.2 95.0 -177.0

P 135.8 6.7 13

Siemens Dimension & SiemensDimension series

14 69.0 -129.0

P 99.0 5.0 206.0 -382.0

P 293.7 9.7 294.0 -546.0

P 420.3 14.5 242.0 -449.0

P 345.4 12.1 88.0 -164.0

P 126.2 6.0 66

Siemens Dimension & SiemensDimension EXL

15 69.0 -128.0

P 98.5 4.8 204.0 -379.0

P 291.2 9.2 291.0 -541.0

P 416.4 12.8 241.0 -447.0

P 344.1 11.7 89.0 -164.0

P 126.5 6.2 17

Siemens Dimension & SiemensDimension Rxl

16 68.0 -126.0

P 96.7 5.6 203.0 -377.0

P 289.9 9.9 289.0 -536.0

P 412.6 10.1 237.0 -440.0

P 338.2 15.5 87.0 -161.0

P 124.0 6.7 14

Siemens Dimension & SiemensDimension Xpand

17 69.0 -128.0

P 98.4 3.5 205.0 -380.0

P 292.5 8.6 293.0 -544.0

P 418.3 11.7 241.0 -448.0

P 344.3 9.6 88.0 -164.0

P 125.9 4.3 74

Initial Grouping by Reagent

Abbott 1883.0 -154.0

P 118.8 2.7234.0 -434.0

P 334.1 6.1332.0 -616.0

P 474.2 8.9276.0 -512.0

P 394.2 5.7105.0 -195.0

P 150.2 2.6 18

Alfa Wassermann 19 75.0 -140.0

P 107.8 4.6 204.0 -379.0

P 291.7 10.5 288.0 -535.0

P 411.8 14.4 242.0 -450.0

P 346.0 15.1 95.0 -176.0

P 135.5 4.9 20

Beckman 2085.0 -157.0

P 120.8 4.8238.0 -442.0

P 340.3 12.5335.0 -622.0

P 478.4 18.1276.0 -512.0

P 394.1 14.9105.0 -195.0

P 150.1 6.3 110

Carolina 21 69.0 -128.0

P 98.5 7.6 195.0 -362.0

P 278.8 19.4 277.0 -514.0

P 395.2 30.1 229.0 -425.0

P 327.0 24.9 87.0 -161.0

P 123.7 9.4 23

Clinical Data ATAC 2268.0 -126.0

P 96.5 10.9203.0 -378.0

P 290.4 10.1289.0 -537.0

P 413.3 18.6235.0 -436.0

P 335.5 19.987.0 -162.0

P 124.5 8.2 11

J&J Vitros 23 71.0 -131.0

P 100.9 7.9 195.0 -362.0

P 278.5 16.9 273.0 -506.0

P 389.5 23.8 237.0 -439.0

P 338.1 20.6 91.0 -170.0

P 130.6 8.8 75

Beckman Olympus 2472.0 -135.0

P 103.5 4.5204.0 -379.0

P 291.8 13.7289.0 -537.0

P 412.8 17.7237.0 -441.0

P 339.1 15.790.0 -168.0

P 129.2 5.9 44

Pointe Sci 25 71.0 -131.0

P 101.1 8.5 196.0 -365.0

P 280.4 24.5 276.0 -513.0

P 394.5 38.1 230.0 -427.0

P 328.1 28.4 88.0 -163.0

P 125.5 10.7 14

Roche Cobas 2678.0 -145.0

P 111.4 5.5218.0 -405.0

P 311.2 12.6309.0 -574.0

P 441.6 18.5256.0 -476.0

P 365.8 15.297.0 -181.0

P 139.1 6.8 36

Roche/Hitachi 27 74.0 -138.0

P 105.9 5.0 207.0 -384.0

P 295.3 15.3 294.0 -547.0

P 420.5 22.9 245.0 -456.0

P 350.4 17.5 93.0 -173.0

P 133.2 5.9 12

Siemens Advia 2875.0 -140.0

P 107.5 5.1214.0 -397.0

P 305.1 13.5304.0 -564.0

P 434.2 19.2252.0 -467.0

P 359.3 15.295.0 -177.0

P 135.8 6.7 13

Siemens Dimension 29 69.0 -128.0

P 98.5 4.4 205.0 -380.0

P 292.6 9.2 293.0 -544.0

P 418.5 12.9 241.0 -447.0

P 344.2 11.4 88.0 -164.0

P 125.9 5.4 171

Initial Grouping by Sensitivity or Principle

Low recovery methods 30 71.0 -131.0

P 100.9 7.9 195.0 -362.0

P 278.5 16.9 273.0 -506.0

P 389.5 23.8 237.0 -439.0

P 338.1 20.6 91.0 -170.0

P 130.6 8.8 75

Low moderate recovery meths 31 72.0 -134.0

P 102.8 7.4 203.0 -376.0

P 289.6 20.8 287.0 -533.0

P 409.9 30.6 237.0 -440.0

P 338.2 24.3 90.0 -167.0

P 128.6 9.4 95

Moderate recovery methods 32 78.0 -145.0

P 111.8 22.2 214.0 -398.0

P 306.1 24.5 302.0 -560.0

P 430.9 41.0 251.0 -466.0

P 358.8 28.8 96.0 -178.0

P 136.7 11.0 64

Page 11: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

High moderate recovery meth 33 75.0 -140.0

P 107.8 4.6 204.0 -379.0

P 291.7 10.5 288.0 -535.0

P 411.8 14.4 242.0 -450.0

P 346.0 15.1 95.0 -176.0

P 135.5 4.9 20

High recovery methods 3469.0 -129.0

P 99.2 5.4205.0 -381.0

P 292.9 11.7294.0 -545.0

P 419.4 16.0241.0 -448.0

P 345.0 13.789.0 -165.0

P 126.7 6.6 189

Very high recovery methods 35 82.0 -152.0

P 116.9 9.3 232.0 -431.0

P 331.4 21.5 327.0 -607.0

P 467.3 28.9 269.0 -500.0

P 384.9 24.8 102.0 -190.0

P 146.3 10.4 159

Total Population

Whole Population 3674.0 -138.0

P 106.0 10.4211.0 -392.0

P 301.9 26.2300.0 -556.0

P 427.9 36.4248.0 -461.0

P 354.8 28.694.0 -174.0

P 134.0 11.9 615

Gamma-Glutamyltransferase (GGT)Initial Grouping by Reagent and Instrument

Abbott & Abbott Architect c, ci, i 1 112.0 -168.0

P 139.8 8.1 48.0 - 72.0 P 59.7 3.5 62.0 - 93.0 P 77.8 4.7 142.0 -213.0

P 177.1 10.2 158.0 -237.0

P 197.7 11.5 10

Alfa Wassermann & Alfa WasserACE/Centr/Alera

2 77.0 -116.0

P 96.8 3.6 34.0 - 54.0 C 43.8 2.5 44.0 - 67.0 P 55.6 2.9 97.0 -146.0

P 121.8 3.9 109.0 -164.0

P 136.4 4.8 20

Beckman & Beckman SynchronCX3/7/9/L

3 111.0 -167.0

P 139.3 8.0 48.0 - 72.0 P 59.9 2.4 61.0 - 92.0 P 76.9 4.9 139.0 -208.0

P 173.7 6.3 158.0 -237.0

P 197.5 7.1 16

Beckman & Beckman Unicel DXCseries

4 117.0 -176.0

P 146.8 5.3 51.0 - 76.0 P 63.5 3.0 66.0 - 99.0 P 82.2 3.6 147.0 -220.0

P 183.5 7.2 166.0 -249.0

P 207.5 7.5 51

Carolina & Beckman SynchronCX3/7/9/L

5 76.0 -114.0

P 95.3 9.8 33.0 - 53.0 C 42.8 5.6 44.0 - 66.0 P 55.1 7.7 96.0 -144.0

P 120.1 12.2 111.0 -166.0

P 138.7 18.9 17

J&J Vitros & J&J Vitros not DT orECi

6 154.0 -231.0

P 192.7 5.5 67.0 -100.0

P 83.7 3.1 87.0 -130.0

P 108.6 3.9 191.0 -287.0

P 239.3 7.5 217.0 -326.0

P 271.5 11.8 34

J&J Vitros & J&J Vitros 5,1 FS 7156.0 -234.0

P 195.3 5.670.0 -106.0

P 88.0 3.289.0 -134.0

P 111.5 2.9190.0 -285.0

P 237.1 5.6214.0 -321.0

P 267.2 7.5 11

Beckman Olympus & Beck Oly AU400/600/5400

8 88.0 -132.0

P 109.9 5.8 38.0 - 58.0 C 47.8 2.2 50.0 - 74.0 P 62.0 3.6 110.0 -165.0

P 137.1 7.1 123.0 -185.0

P 154.3 7.9 29

Roche Cobas & Roche CobasIntegra

995.0 -143.0

P 118.8 3.3 40.0 - 60.0 C 49.8 2.3 52.0 - 78.0 P 65.2 2.4119.0 -179.0

P 149.0 4.6134.0 -201.0

P 167.8 5.3 13

Siemens & Siemens Advia series 10 103.0 -155.0

P 128.8 5.4 44.0 - 66.0 P 55.4 2.3 57.0 - 86.0 P 71.5 3.5 130.0 -195.0

P 162.2 7.5 146.0 -219.0

P 182.7 8.0 13

Siemens Dimension & SiemensDimension series

11127.0 -190.0

P 158.7 4.5 57.0 - 86.0 P 71.8 2.974.0 -111.0

P 92.8 3.7159.0 -239.0

P 199.1 5.8178.0 -268.0

P 223.1 5.7 34

Siemens Dimension & SiemensDimension EXL

12 127.0 -191.0

P 159.2 3.2 58.0 - 87.0 P 72.2 1.5 75.0 -112.0

P 93.4 1.6 160.0 -239.0

P 199.4 3.4 178.0 -267.0

P 222.7 4.2 12

Siemens Dimension & SiemensDimension Xpand

13126.0 -189.0

P 157.6 4.1 57.0 - 86.0 P 71.6 2.774.0 -111.0

P 92.3 3.0159.0 -239.0

P 198.8 5.8178.0 -267.0

P 222.5 5.9 28

Initial Grouping by Reagent

Abbott 14 113.0 -169.0

P 141.1 8.7 48.0 - 72.0 P 60.3 3.8 63.0 - 94.0 P 78.5 5.2 143.0 -215.0

P 178.8 10.7 160.0 -240.0

P 199.9 12.5 12

Alfa Wassermann 15 77.0 -116.0

P 96.8 3.6 34.0 - 54.0 C 43.8 2.5 44.0 - 67.0 P 55.6 2.9 97.0 -146.0

P 121.8 3.9 109.0 -164.0

P 136.4 4.8 20

Beckman 16 115.0 -173.0

P 144.1 6.8 50.0 - 75.0 P 62.5 3.3 64.0 - 97.0 P 80.6 4.6 144.0 -216.0

P 180.3 8.2 163.0 -245.0

P 204.0 8.7 83

Page 12: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Carolina 17 76.0 -114.0

P 95.1 9.1 32.0 - 52.0 C 42.5 5.1 44.0 - 66.0 P 54.7 7.0 96.0 -144.0

P 119.9 11.2 110.0 -165.0

P 137.1 17.1 22

DCL/Genzyme 1897.0 -146.0

P 121.5 13.7 42.0 - 63.0 P 52.3 5.9 55.0 - 83.0 P 68.8 9.0122.0 -183.0

P 152.5 17.1138.0 -206.0

P 171.9 20.3 12

J&J Vitros 19 155.0 -232.0

P 193.7 5.8 68.0 -102.0

P 85.2 3.9 88.0 -132.0

P 109.7 4.2 191.0 -286.0

P 238.6 7.0 216.0 -325.0

P 270.4 10.6 49

Beckman Olympus 20 89.0 -133.0

P 110.9 6.7 38.0 - 58.0 C 48.1 2.4 50.0 - 75.0 P 62.6 4.0 110.0 -165.0

P 137.5 7.0 124.0 -186.0

P 154.9 7.8 33

Roche Cobas 21 97.0 -146.0

P 121.3 5.1 40.0 - 60.0 P 50.1 4.1 53.0 - 80.0 P 66.3 3.4 122.0 -183.0

P 152.5 6.5 136.0 -204.0

P 170.0 11.9 23

Roche/Hitachi 9xx/Mod Szasz 22 101.0 -151.0

P 125.9 5.5 42.0 - 63.0 P 52.9 2.5 56.0 - 83.0 P 69.5 3.4 126.0 -189.0

P 157.3 2.8 142.0 -213.0

P 177.7 4.5 12

Siemens 23 102.0 -153.0

P 127.5 6.2 44.0 - 66.0 P 55.0 2.4 57.0 - 85.0 P 71.0 3.6 128.0 -193.0

P 160.5 8.4 145.0 -217.0

P 180.9 9.2 15

Siemens Dimension 24 127.0 -190.0

P 158.1 4.1 57.0 - 86.0 P 71.7 2.6 74.0 -111.0

P 92.6 3.1 159.0 -239.0

P 198.9 5.3 178.0 -267.0

P 222.5 5.4 82

Initial Grouping by Sensitivity or Principle

Low moderate recovery meth 25 84.0 -127.0

P 105.6 10.4 37.0 - 57.0 C 47.0 6.9 48.0 - 72.0 P 60.2 6.6 107.0 -160.0

P 133.2 14.2 118.0 -177.0

P 147.9 13.7 75

Moderate recovery methods 2692.0 -139.0

P 115.6 15.4 39.0 - 59.0 C 49.5 6.5 52.0 - 78.0 P 64.6 8.8116.0 -174.0

P 144.9 18.3131.0 -196.0

P 163.2 21.8 93

High moderate recovery meth 27 100.0 -150.0

P 125.3 7.1 43.0 - 65.0 P 54.1 2.9 56.0 - 85.0 P 70.6 4.5 126.0 -189.0

P 157.4 10.0 142.0 -212.0

P 177.1 11.8 19

High recovery methods 28115.0 -173.0

P 143.8 7.0 50.0 - 75.0 P 62.2 3.5 64.0 - 96.0 P 80.3 4.7144.0 -216.0

P 180.0 8.5163.0 -244.0

P 203.4 9.3 96

Very high recovery methods 29 137.0 -206.0

P 171.4 17.9 61.0 - 92.0 P 76.8 7.3 79.0 -119.0

P 99.0 9.0 171.0 -256.0

P 213.7 20.2 192.0 -288.0

P 240.3 24.5 131

Total Population

Whole Population 30 106.0 -159.0

P 132.9 22.2 47.0 - 70.0 P 58.5 10.6 60.0 - 91.0 P 75.6 13.5 134.0 -201.0

P 167.7 28.8 151.0 -226.0

P 188.2 32.2 420

Human Chorionic Gonadotropin (hCG)Initial Grouping by Reagent and Instrument

Abbott Total b-hCG & AbbottAxSYM

1 1457.0 -2467.0

S 1962.0 168.4 466.0 -611.0

S 538.8 24.1 617.0 -996.0

S 806.3 63.1 2081.0 -3065.0

S 2573.3 164.1 2277.0 -3597.0

S 2936.8 220.0 19

Beckman Access & BeckmanAccess luminometer

2 1123.0 -1975.0

S 1548.9 141.9 362.0 -479.0

S 420.7 19.5 523.0 -711.0

S 617.3 31.3 1551.0 -2460.0

S 2005.7 151.5 1695.0 -2893.0

S 2293.8 199.7 58

bioMerieux Vidas & bioMerieuxmini Vidas/Vidas

3 1066.0 -2360.0

S 1712.8 215.6 370.0 -700.0

S 534.7 54.9 593.0 -992.0

S 792.4 66.6 1097.0 -3124.0

S 2110.3 337.9 1658.0 -3548.0

S 2602.5 315.0 24

J&J Vitros ECi & J&J Vitros ECi 4 1528.0 -1881.0

S 1704.4 58.9 453.0 -558.0

S 505.6 17.5 646.0 -839.0

S 742.3 32.2 1870.0 -2426.0

S 2148.1 92.7 2357.0 -2766.0

S 2561.6 68.2 16

Roche Elecsys & Roche Elecsysseries

5 976.0 -1954.0

S 1465.4 163.0 304.0 -593.0

S 448.6 48.3 455.0 -885.0

S 670.0 71.6 1262.0 -2542.0

S 1902.0 213.4 1554.0 -2826.0

S 2190.3 212.0 11

Siemens Advia & SiemensCentaur/Centaur CP

6 1019.0 -1835.0

S 1427.4 136.0 402.0 -536.0

S 469.4 22.3 538.0 -767.0

S 652.5 38.3 1268.0 -2374.0

S 1821.2 184.4 1507.0 -2732.0

S 2119.5 204.3 18

Page 13: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Siemens Dimension & SiemensDimension series

7 1061.0 -2185.0

S 1623.0 187.4 367.0 -534.0

S 450.8 27.9 533.0 -767.0

S 650.3 39.0 1470.0 -2701.0

S 2085.1 205.2 1562.0 -3264.0

S 2413.0 283.7 21

Siemens Dimension & SiemensDimension EXL

8930.0 -2213.0

S 1571.8 213.8377.0 -502.0

S 439.5 20.9551.0 -698.0

S 624.5 24.41211.0 -2876.0

S 2043.2 277.51287.0 -3312.0

S 2299.3 337.6 12

Siemens Dimension & SiemensDimension Xpand

9 1157.0 -2130.0

S 1643.3 162.1 393.0 -486.0

S 439.2 15.5 562.0 -699.0

S 630.8 22.8 1522.0 -2690.0

S 2106.2 194.7 1807.0 -2971.0

S 2389.0 193.9 21

Siemens Immulite & SiemensImmulite/Immul 1000

10 1272.0 -2205.0

S 1738.8 155.5 426.0 -665.0

S 545.5 39.7 637.0 -949.0

S 793.2 52.1 1516.0 -2933.0

S 2224.5 236.0 1807.0 -3379.0

S 2592.7 262.0 60

Siemens Immulite 2000 &Siemens Immulite 2000

11 1448.0 -2296.0

S 1872.3 141.4 488.0 -707.0

S 597.7 36.6 601.0 -1124.0

S 862.6 87.3 1443.0 -3083.0

S 2263.3 273.3 1909.0 -3663.0

S 2786.0 292.4 19

Tosoh Total b-hCG & TosohMedics ST AIA

12 1122.0 -2416.0

S 1769.3 215.6 280.0 -719.0

S 499.5 73.2 619.0 -978.0

S 798.7 59.8 1588.0 -2854.0

S 2221.1 211.1 1841.0 -3270.0

S 2555.8 238.2 16

Initial Grouping by Reagent

Abbott Total b-hCG 13 1258.0 -2571.0

S 1914.7 218.8 422.0 -638.0

S 529.8 35.9 570.0 -1014.0

S 792.0 74.1 1665.0 -3335.0

S 2500.3 278.3 1944.0 -3787.0

S 2865.4 307.3 21

Beckman Access 141109.0 -1983.0

S 1546.3 145.6357.0 -484.0

S 420.2 21.1518.0 -713.0

S 615.3 32.51559.0 -2459.0

S 2009.3 150.11670.0 -2888.0

S 2278.8 203.1 66

bioMerieux Vidas 15 1066.0 -2360.0

S 1712.8 215.6 370.0 -700.0

S 534.7 54.9 593.0 -992.0

S 792.4 66.6 1097.0 -3124.0

S 2110.3 337.9 1658.0 -3548.0

S 2602.5 315.0 24

J&J Vitros ECi 161537.0 -1863.0

S 1699.8 54.4456.0 -552.0

S 504.3 16.0650.0 -831.0

S 740.2 30.11885.0 -2402.0

S 2143.6 86.22334.0 -2782.0

S 2558.1 74.6 20

Roche Elecsys 17 988.0 -1893.0

S 1440.5 150.8 311.0 -574.0

S 442.6 43.9 455.0 -866.0

S 660.2 68.6 1260.0 -2481.0

S 1870.3 203.5 1536.0 -2788.0

S 2161.9 208.6 17

Roche HCG+b 181216.0 -1773.0

S 1494.5 92.7373.0 -539.0

S 455.9 27.8565.0 -793.0

S 679.0 37.91574.0 -2271.0

S 1922.2 116.21787.0 -2666.0

S 2226.1 146.5 10

Siemens Advia 19 1052.0 -1815.0

S 1433.4 127.1 397.0 -551.0

S 474.1 25.6 540.0 -769.0

S 654.7 38.1 1308.0 -2347.0

S 1827.2 173.1 1549.0 -2691.0

S 2120.0 190.2 21

Siemens Dimension 20 1081.0 -2158.0

S 1619.3 179.6 373.0 -513.0

S 443.3 23.3 535.0 -737.0

S 636.3 33.7 1429.0 -2704.0

S 2066.8 212.6 1621.0 -3120.0

S 2370.1 249.8 65

Siemens Immulite 21 1278.0 -2218.0

S 1748.2 156.7 430.0 -669.0

S 549.1 39.8 635.0 -962.0

S 798.5 54.5 1518.0 -2932.0

S 2225.0 235.7 1835.0 -3354.0

S 2594.2 253.2 67

Siemens Immulite 2000 22 1447.0 -2320.0

S 1883.3 145.5 480.0 -725.0

S 602.3 40.8 608.0 -1120.0

S 864.3 85.3 1445.0 -3120.0

S 2282.3 279.3 1936.0 -3643.0

S 2789.4 284.5 20

Tosoh Total b-hCG 23 1196.0 -2314.0

S 1755.0 186.5 323.0 -701.0

S 511.7 63.0 629.0 -968.0

S 798.6 56.6 1649.0 -2825.0

S 2236.7 196.0 1942.0 -3171.0

S 2556.6 204.7 24

Initial Grouping by Sensitivity or Principle

Moderate recovery methods 24 823.0 -2290.0

S 1556.6 244.5 324.0 -606.0

S 465.2 47.0 449.0 -897.0

S 673.0 74.7 1153.0 -2827.0

S 1990.0 278.9 1346.0 -3274.0

S 2309.9 321.4 155

High recovery methods 251132.0 -2500.0

S 1815.8 228.1367.0 -676.0

S 521.4 51.6605.0 -991.0

S 798.1 64.41503.0 -3185.0

S 2344.1 280.31745.0 -3625.0

S 2684.8 313.3 47

Very high recovery methods 26 1300.0 -2267.0

S 1783.6 161.2 427.0 -698.0

S 562.7 45.3 607.0 -1031.0

S 818.7 70.6 1513.0 -2987.0

S 2250.0 245.6 1819.0 -3502.0

S 2660.9 280.5 92

All other methods 271144.0 -2017.0

S 1580.6 145.6317.0 -563.0

S 439.8 40.9459.0 -830.0

S 644.4 61.91595.0 -2487.0

S 2040.9 148.81692.0 -2990.0

S 2341.2 216.3 86

Total Population

Page 14: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Whole Population 28 1039.0 -2266.0

S 1652.4 204.4 297.0 -678.0

S 487.7 63.4 428.0 -998.0

S 712.9 95.1 1329.0 -2885.0

S 2106.7 259.3 1542.0 -3355.0

S 2448.9 302.2 393

IronInitial Grouping by Reagent and Instrument

Alfa Wassermann & Alfa WasserACE/Centr/Alera

1108.0 -162.0

P 134.6 20.7122.0 -183.0

P 152.6 3.5161.0 -242.0

P 201.6 4.3180.0 -270.0

P 225.3 6.2128.0 -192.0

P 159.6 3.7 11

Beckman Ferrozine & BeckmanSynchron CX3/7/9/L

2 103.0 -154.0

P 128.7 7.4 127.0 -191.0

P 158.9 5.5 170.0 -255.0

P 212.1 6.3 185.0 -277.0

P 231.1 6.8 131.0 -197.0

P 163.8 8.4 16

Beckman Ferrozine & BeckmanUnicel DXC series

3105.0 -158.0

P 131.6 6.7131.0 -196.0

P 163.4 6.2174.0 -261.0

P 217.5 7.1191.0 -286.0

P 238.2 8.7134.0 -202.0

P 168.0 8.9 51

Carolina & Beckman SynchronCX3/7/9/L

4 102.0 -153.0

P 127.6 8.4 122.0 -182.0

P 152.0 12.4 165.0 -247.0

P 206.2 13.2 183.0 -275.0

P 229.0 18.8 133.0 -199.0

P 166.2 10.6 20

J&J Vitros & J&J Vitros not DT orECi

5115.0 -172.0

P 143.1 9.0138.0 -208.0

P 173.0 10.8189.0 -283.0

P 236.2 11.2216.0 -325.0

P 270.5 12.5152.0 -228.0

P 189.8 10.7 21

J&J Vitros & J&J Vitros 5,1 FS 6 116.0 -174.0

P 145.0 6.8 138.0 -207.0

P 172.7 7.8 188.0 -282.0

P 235.0 7.0 213.0 -320.0

P 266.4 6.9 155.0 -232.0

P 193.5 6.3 12

Beckman Olympus Ferene & BeckOly AU 400/600/5400

7113.0 -170.0

P 141.5 3.9139.0 -208.0

P 173.4 3.3186.0 -280.0

P 233.1 4.7204.0 -306.0

P 254.9 6.4145.0 -218.0

P 181.5 5.7 13

Roche Cobas & Roche CobasIntegra

8 109.0 -163.0

P 135.7 5.4 132.0 -198.0

P 164.6 3.8 177.0 -265.0

P 220.9 4.7 200.0 -299.0

P 249.4 2.7 147.0 -221.0

P 183.9 3.4 14

Siemens Advia Iron_2 & SiemensAdvia series

9110.0 -165.0

P 137.1 2.6130.0 -195.0

P 162.7 3.6177.0 -266.0

P 221.7 5.8202.0 -303.0

P 252.4 8.7145.0 -218.0

P 181.3 4.4 12

Siemens Dimension & SiemensDimension series

10 101.0 -152.0

P 126.8 3.0 122.0 -184.0

P 152.9 4.0 165.0 -248.0

P 206.8 3.4 188.0 -281.0

P 234.5 3.6 134.0 -201.0

P 167.3 3.0 25

Siemens Dimension & SiemensDimension Rxl

11 102.0 -154.0

P 128.1 2.0 124.0 -186.0

P 155.1 2.3 167.0 -250.0

P 208.4 2.5 188.0 -281.0

P 234.6 2.5 134.0 -202.0

P 168.0 2.8 10

Siemens Dimension & SiemensDimension Xpand

12 103.0 -154.0

P 128.2 2.3 124.0 -186.0

P 154.8 4.2 167.0 -250.0

P 208.4 5.0 189.0 -283.0

P 236.1 4.4 134.0 -201.0

P 167.5 3.3 31

Sterling Ferrozine & Otherspectrophotometers

13 105.0 -158.0

P 131.8 10.0 123.0 -185.0

P 154.0 7.7 172.0 -259.0

P 215.5 12.2 186.0 -279.0

P 232.5 9.0 134.0 -201.0

P 167.3 12.5 13

Olympus tripyridyltriazine & BeckOly AU 400/600/5400

14 113.0 -170.0

P 141.8 6.7 139.0 -209.0

P 174.2 6.4 187.0 -280.0

P 233.2 8.2 205.0 -308.0

P 256.8 10.5 146.0 -220.0

P 183.0 8.9 12

Initial Grouping by Reagent

Alfa Wassermann 15 108.0 -162.0

P 134.6 20.7 122.0 -183.0

P 152.6 3.5 161.0 -242.0

P 201.6 4.3 180.0 -270.0

P 225.3 6.2 128.0 -192.0

P 159.6 3.7 11

Beckman Ferrozine 16105.0 -157.0

P 131.1 6.8130.0 -195.0

P 162.7 6.2173.0 -260.0

P 216.5 7.1189.0 -284.0

P 236.7 8.6134.0 -201.0

P 167.2 8.5 80

Carolina 17 102.0 -153.0

P 127.4 12.4 122.0 -184.0

P 153.0 14.3 164.0 -246.0

P 204.9 14.8 182.0 -273.0

P 227.5 19.0 131.0 -197.0

P 164.0 13.4 30

DCL/Genzyme 1894.0 -141.0

P 117.5 10.3112.0 -167.0

P 139.6 12.3151.0 -227.0

P 189.2 15.3176.0 -264.0

P 220.1 16.4126.0 -188.0

P 157.0 11.7 22

J&J Vitros 19 115.0 -173.0

P 144.2 7.8 139.0 -208.0

P 173.3 9.2 189.0 -283.0

P 235.7 9.7 215.0 -322.0

P 268.2 10.7 153.0 -229.0

P 190.7 9.1 38

113.0 - 139.0 - 186.0 - 204.0 - 145.0 -

Page 15: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Beckman Olympus Ferene 20 170.0 P 141.5 3.9 208.0 P 173.4 3.3 280.0 P 233.1 4.7 306.0 P 254.9 6.4 218.0 P 181.5 5.7 13

Roche Cobas 21 110.0 -164.0

P 137.1 5.0 132.0 -198.0

P 164.6 3.9 177.0 -265.0

P 221.0 5.0 201.0 -301.0

P 250.9 4.5 146.0 -220.0

P 183.1 4.0 26

Roche DGKC 22 108.0 -163.0

P 135.4 3.7 128.0 -192.0

P 160.0 3.9 172.0 -259.0

P 215.6 4.5 195.0 -293.0

P 244.2 4.8 142.0 -213.0

P 177.8 3.1 13

Siemens Advia Iron_2 23 110.0 -165.0

P 137.1 2.6 130.0 -195.0

P 162.7 3.6 177.0 -266.0

P 221.7 5.8 202.0 -303.0

P 252.4 8.7 145.0 -218.0

P 181.3 4.4 12

Siemens Dimension 24 102.0 -153.0

P 127.8 2.5 123.0 -185.0

P 154.3 3.9 166.0 -250.0

P 208.0 4.1 188.0 -282.0

P 235.4 3.8 134.0 -201.0

P 167.5 3.0 73

Sterling Ferrozine 25 106.0 -160.0

P 133.1 11.5 123.0 -184.0

P 153.7 7.5 173.0 -260.0

P 216.6 13.1 188.0 -282.0

P 235.1 11.5 135.0 -203.0

P 168.8 12.1 15

Olympus tripyridyltriazine 26 113.0 -170.0

P 141.2 6.4 139.0 -208.0

P 173.7 6.0 186.0 -278.0

P 232.1 7.8 204.0 -306.0

P 254.8 10.9 145.0 -218.0

P 181.6 9.0 16

Initial Grouping by Sensitivity or Principle

Ferene-based 27102.0 -152.0

P 127.0 10.1123.0 -185.0

P 153.9 12.2165.0 -248.0

P 206.5 16.6186.0 -279.0

P 232.2 15.9132.0 -198.0

P 165.3 11.6 164

Ferrozine-based 28 106.0 -159.0

P 132.2 9.8 128.0 -192.0

P 160.1 8.9 172.0 -258.0

P 214.9 11.2 190.0 -286.0

P 238.1 13.6 136.0 -204.0

P 169.7 12.8 185

Tripyridyltriazine (TPTZ) 29113.0 -170.0

P 141.3 5.9139.0 -208.0

P 173.3 5.8185.0 -277.0

P 230.7 9.5202.0 -302.0

P 252.1 16.7150.0 -225.0

P 187.5 26.6 20

All other methods 30 115.0 -173.0

P 144.2 7.8 139.0 -208.0

P 173.3 9.2 189.0 -283.0

P 235.7 9.7 215.0 -322.0

P 268.2 10.7 153.0 -229.0

P 190.7 9.1 38

Total Population

Whole Population 31 105.0 -158.0

P 131.4 10.7 127.0 -191.0

P 159.3 12.1 171.0 -257.0

P 214.3 15.6 191.0 -287.0

P 239.1 17.7 136.0 -205.0

P 170.4 13.6 415

Lactate Dehydrogenase, Total (LD or LDH)Initial Grouping by Reagent and Instrument

Abbott & Abbott Architect c, ci, i 1338.0 -506.0

P 421.9 7.0146.0 -219.0

P 182.4 6.5170.0 -255.0

P 212.1 6.5386.0 -578.0

P 481.9 7.6455.0 -683.0

P 568.9 9.8 11

Alfa Wassermann & Alfa WasserACE/Centr/Alera

2 248.0 -371.0

P 309.5 10.6 105.0 -157.0

P 130.7 5.6 120.0 -179.0

P 149.6 7.8 275.0 -412.0

P 343.5 10.4 328.0 -492.0

P 410.0 12.1 23

Beckman & Beckman SynchronCX4/CX5

3290.0 -435.0

P 362.2 11.2121.0 -181.0

P 150.7 3.6140.0 -210.0

P 174.9 4.4326.0 -489.0

P 407.7 13.0388.0 -582.0

P 485.2 15.5 10

Beckman & Beckman SynchronCX3/7/9/L

4 289.0 -434.0

P 361.8 8.4 120.0 -180.0

P 149.9 4.7 139.0 -209.0

P 174.1 5.7 326.0 -489.0

P 407.7 12.3 390.0 -585.0

P 487.8 16.1 16

Beckman & Beckman Unicel DXCseries

5297.0 -446.0

P 371.8 12.9123.0 -184.0

P 153.4 5.4144.0 -216.0

P 179.6 6.9336.0 -504.0

P 419.9 13.5399.0 -599.0

P 499.1 16.4 55

Carolina & Beckman SynchronCX3/7/9/L

6 262.0 -393.0

P 327.6 12.6 115.0 -173.0

P 143.8 7.0 133.0 -200.0

P 166.4 8.1 295.0 -442.0

P 368.7 18.5 347.0 -521.0

P 434.0 20.9 13

J&J Vitros & J&J Vitros not DT orECi

71293.0 -1939.0

P 1615.6 48.9493.0 -739.0

P 615.9 14.9561.0 -841.0

P 700.9 18.61402.0 -2102.0

P 1752.0 60.21767.0 -2650.0

P 2208.2 98.7 41

J&J Vitros & J&J Vitros 5,1 FS 8 1294.0 -1940.0

P 1617.1 29.9 499.0 -748.0

P 623.4 14.4 561.0 -842.0

P 701.6 22.7 1401.0 -2102.0

P 1751.5 33.8 1750.0 -2625.0

P 2187.2 37.4 13

Page 16: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Beckman Olympus & Beck Oly AU400/600/5400

9 306.0 -459.0

P 382.6 24.0 124.0 -187.0

P 155.6 9.5 145.0 -217.0

P 180.8 11.2 342.0 -513.0

P 427.7 26.1 412.0 -619.0

P 515.6 32.1 31

Roche Cobas & Roche CobasIntegra

10360.0 -540.0

P 450.1 15.1149.0 -224.0

P 186.4 6.9173.0 -259.0

P 215.7 8.3404.0 -605.0

P 504.5 15.7485.0 -727.0

P 605.7 19.8 10

Siemens & Siemens Advia series 11 355.0 -532.0

P 443.2 18.2 148.0 -222.0

P 184.8 7.6 173.0 -259.0

P 215.9 9.3 400.0 -600.0

P 500.3 21.4 476.0 -715.0

P 595.6 26.8 13

Siemens Dimension & SiemensDimension series

12 304.0 -455.0

P 379.5 12.7 126.0 -189.0

P 157.9 6.2 147.0 -221.0

P 184.2 6.7 341.0 -512.0

P 426.9 13.6 407.0 -611.0

P 508.8 17.5 42

Siemens Dimension & SiemensDimension EXL

13 309.0 -463.0

P 385.8 8.2 129.0 -193.0

P 160.6 3.2 150.0 -225.0

P 187.3 3.0 349.0 -524.0

P 436.5 7.3 415.0 -623.0

P 519.1 18.6 11

Siemens Dimension & SiemensDimension Xpand

14 306.0 -459.0

P 382.4 12.2 128.0 -192.0

P 159.9 7.1 149.0 -224.0

P 186.3 7.1 346.0 -519.0

P 432.6 11.6 412.0 -618.0

P 515.3 19.0 54

Initial Grouping by Method

Abbott 15 341.0 -511.0

P 425.9 10.2 147.0 -221.0

P 183.8 7.1 171.0 -257.0

P 213.9 7.4 389.0 -583.0

P 485.8 10.5 459.0 -688.0

P 573.4 14.0 14

Alfa Wassermann 16248.0 -371.0

P 309.5 10.6105.0 -157.0

P 130.7 5.6120.0 -179.0

P 149.6 7.8275.0 -412.0

P 343.5 10.4328.0 -492.0

P 410.0 12.1 23

Beckman 17 295.0 -443.0

P 369.0 12.9 122.0 -183.0

P 152.4 5.5 142.0 -213.0

P 177.9 6.9 333.0 -499.0

P 416.2 14.8 396.0 -594.0

P 495.2 17.3 87

Carolina 18261.0 -392.0

P 326.7 13.0116.0 -173.0

P 144.4 8.2134.0 -201.0

P 167.4 9.4297.0 -446.0

P 371.6 22.8350.0 -524.0

P 437.1 26.7 17

DCL/Genzyme 19 305.0 -458.0

P 381.4 36.3 126.0 -190.0

P 158.1 16.5 146.0 -219.0

P 182.3 18.4 341.0 -511.0

P 425.7 41.1 404.0 -606.0

P 505.1 55.9 10

J&J Vitros 201293.0 -1939.0

P 1616.1 48.7494.0 -740.0

P 616.9 15.0560.0 -840.0

P 700.4 19.61399.0 -2098.0

P 1748.5 58.21767.0 -2651.0

P 2209.0 89.5 59

Beckman Olympus 21 307.0 -461.0

P 384.1 23.1 125.0 -188.0

P 156.5 9.4 145.0 -218.0

P 181.6 10.9 344.0 -516.0

P 430.1 25.8 414.0 -622.0

P 518.1 31.5 35

Roche Cobas 22 357.0 -536.0

P 446.4 12.7 148.0 -221.0

P 184.6 5.6 171.0 -256.0

P 213.6 6.7 401.0 -602.0

P 501.5 12.9 481.0 -721.0

P 600.8 17.9 21

Roche/Hitachi 9xx/Mod IFCC 23 353.0 -530.0

P 441.4 3.4 145.0 -218.0

P 181.7 2.6 169.0 -254.0

P 211.3 2.7 399.0 -598.0

P 498.2 6.7 479.0 -718.0

P 598.4 8.5 10

Roche/Hitachi/Integra ver.2 24 352.0 -529.0

P 440.5 9.9 145.0 -217.0

P 180.9 4.7 168.0 -252.0

P 210.1 5.5 394.0 -591.0

P 492.6 11.4 473.0 -709.0

P 591.0 13.1 10

Siemens 25 355.0 -532.0

P 443.2 18.2 148.0 -222.0

P 184.8 7.6 173.0 -259.0

P 215.9 9.3 400.0 -600.0

P 500.3 21.4 476.0 -715.0

P 595.6 26.8 13

Siemens Dimension 26 305.0 -458.0

P 381.5 12.1 127.0 -191.0

P 159.2 6.4 148.0 -222.0

P 185.4 6.6 344.0 -516.0

P 430.2 12.7 410.0 -615.0

P 512.7 18.6 115

Initial Grouping by Sensitivity or Principle

Low recovery methods 27248.0 -371.0

P 309.5 10.6105.0 -157.0

P 130.7 5.6120.0 -179.0

P 149.6 7.8275.0 -412.0

P 343.5 10.4328.0 -492.0

P 410.0 12.1 23

Low moderate recovery meths 28 296.0 -444.0

P 370.2 27.5 123.0 -184.0

P 153.5 9.4 143.0 -215.0

P 179.0 11.8 333.0 -500.0

P 416.8 29.1 398.0 -597.0

P 497.8 37.2 150

Moderate recovery methods 29308.0 -463.0

P 385.6 21.5129.0 -194.0

P 161.4 10.9150.0 -225.0

P 187.7 12.5348.0 -522.0

P 435.2 25.3414.0 -622.0

P 518.1 31.1 151

High moderate recovery meth 30 344.0 -515.0

P 429.4 36.2 142.0 -213.0

P 177.6 18.4 166.0 -249.0

P 207.7 15.5 387.0 -581.0

P 483.8 37.6 462.0 -692.0

P 577.0 44.2 49

Page 17: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

High recovery methods 31 354.0 -530.0

P 442.0 8.7 146.0 -218.0

P 181.9 4.7 169.0 -253.0

P 211.2 4.7 397.0 -596.0

P 496.2 10.4 476.0 -714.0

P 595.4 11.8 21

All other methods 321293.0 -1939.0

P 1616.1 48.7494.0 -740.0

P 616.9 15.0560.0 -840.0

P 700.4 19.61399.0 -2098.0

P 1748.5 58.21767.0 -2651.0

P 2209.0 89.5 59

Total Population

Whole Population 33 316.0 -474.0

P 394.7 29.4 130.0 -195.0

P 162.5 13.2 151.0 -227.0

P 189.1 15.3 355.0 -532.0

P 443.3 32.9 425.0 -637.0

P 531.1 39.9 460

LipaseInitial Grouping by Reagent and Instrument

Beckman LIP & Beckman UnicelDXC series

1 16.0 - 30.0 P 22.8 1.9 48.0 - 89.0 P 68.6 4.7 63.0 -118.0

P 90.7 7.1 54.0 -101.0

P 77.8 5.6 21.0 - 38.0 P 29.5 2.2 32

Carolina & Beckman SynchronCX3/7/9/L

2 18.0 - 34.0 P 26.0 4.7 52.0 - 97.0 P 74.6 7.4 69.0 -129.0

P 98.8 10.3 60.0 -111.0

P 85.2 11.9 22.0 - 42.0 P 32.1 4.6 14

J&J Vitros & J&J Vitros not DT orECi

3 190.0 -353.0

P 271.7 9.6 850.0 -1579.0

P 1214.8 31.3 1226.0 -2278.0

P 1752.0 47.5 961.0 -1785.0

P 1372.9 37.7 275.0 -511.0

P 393.2 13.3 35

J&J Vitros & J&J Vitros 5,1 FS 4 182.0 -338.0

P 260.1 7.9 827.0 -1536.0

P 1181.7 20.2 1186.0 -2203.0

P 1694.9 31.1 936.0 -1739.0

P 1337.4 29.7 264.0 -491.0

P 377.6 13.0 14

Beckman Olympus & Beck Oly AU400/600/5400

5 15.0 - 27.0 P 21.0 2.8 60.0 -112.0

P 86.2 6.3 85.0 -159.0

P 122.1 8.1 68.0 -127.0

P 97.8 6.9 20.0 - 36.0 P 28.0 3.3 20

Roche Cobas Integra & RocheCobas Integra

6 15.0 - 28.0 P 21.6 1.2 51.0 - 94.0 P 72.2 3.2 71.0 -132.0

P 101.4 4.1 58.0 -108.0

P 83.2 3.1 19.0 - 36.0 P 27.7 1.2 18

Siemens LIPL, liquid & SiemensDimension series

7 101.0 -187.0

P 143.6 44.2 257.0 -478.0

P 367.7 69.9 348.0 -645.0

P 496.4 78.9 291.0 -540.0

P 415.6 72.3 120.0 -223.0

P 171.5 46.9 25

Siemens LIPL, liquid & SiemensDimension Xpand

8120.0 -222.0

P 170.8 10.0261.0 -484.0

P 372.2 71.9352.0 -653.0

P 502.5 89.0296.0 -549.0

P 422.6 78.8121.0 -225.0

P 172.8 47.7 22

Siemens LIPL, tableted &Siemens Dimension Xpand

9 61.0 -114.0

P 87.8 4.0 197.0 -366.0

P 281.2 7.5 278.0 -517.0

P 397.6 9.2 230.0 -427.0

P 328.2 8.9 79.0 -147.0

P 112.9 3.7 14

Initial Grouping by Reagent

Abbott Architec/ Aeroset 10 13.0 - 24.0 P 18.8 1.2 53.0 - 98.0 P 75.7 3.5 76.0 -140.0

P 107.9 4.7 61.0 -113.0

P 86.6 3.7 18.0 - 33.0 P 25.1 1.3 10

Beckman LIP 11 16.0 - 30.0 P 23.0 2.7 48.0 - 89.0 P 68.5 5.1 63.0 -118.0

P 90.4 7.4 54.0 -101.0

P 77.7 5.8 21.0 - 38.0 P 29.5 2.7 39

Beckman LIPA 12 15.0 - 29.0 P 21.9 2.6 49.0 - 91.0 P 69.7 8.7 67.0 -125.0

P 96.2 16.6 55.0 -102.0

P 78.8 9.5 20.0 - 38.0 P 29.0 4.5 18

Carolina 13 18.0 - 34.0 P 26.0 4.3 53.0 - 98.0 P 75.0 8.4 68.0 -125.0

P 96.5 12.5 58.0 -107.0

P 82.6 9.7 23.0 - 42.0 P 32.4 4.5 20

J&J Vitros 14 188.0 -349.0

P 268.2 10.5 843.0 -1566.0

P 1204.9 34.8 1214.0 -2255.0

P 1734.6 50.7 953.0 -1771.0

P 1361.9 38.4 272.0 -505.0

P 388.2 15.0 54

Beckman Olympus 15 15.0 - 27.0 P 21.2 2.8 60.0 -112.0

P 86.0 6.2 85.0 -159.0

P 122.0 7.9 68.0 -127.0

P 97.7 6.7 20.0 - 36.0 P 28.0 3.2 21

Roche Cobas Integra 16 15.0 - 28.0 P 21.4 1.7 49.0 - 91.0 P 70.2 5.1 69.0 -128.0

P 98.1 7.2 56.0 -104.0

P 80.0 6.6 19.0 - 35.0 P 27.0 1.7 24

Roche/Hitachi 17 14.0 - 26.0 P 20.1 0.7 45.0 - 84.0 P 64.3 2.5 63.0 -117.0

P 89.7 4.2 52.0 - 96.0 P 73.6 3.1 18.0 - 33.0 P 25.5 1.0 15

Page 18: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Siemens LIPL, liquid 18 98.0 -183.0

P 140.6 42.9 250.0 -465.0

P 357.7 73.0 340.0 -631.0

P 485.5 88.1 284.0 -528.0

P 406.1 78.9 115.0 -213.0

P 163.6 48.1 65

Siemens Dimension 1997.0 -179.0

P 138.1 44.1261.0 -485.0

P 373.1 67.6358.0 -664.0

P 510.9 87.9290.0 -540.0

P 415.0 77.0114.0 -212.0

P 163.4 45.6 14

Siemens LIPL, tableted 20 62.0 -115.0

P 88.8 3.9 197.0 -367.0

P 282.1 6.8 280.0 -521.0

P 400.7 11.3 230.0 -428.0

P 329.0 8.6 79.0 -147.0

P 113.4 3.8 25

Initial Grouping by Sensitivity or Principle

Very low recovery methods 21 17.0 - 31.0 P 24.1 4.961.0 -113.0

P 87.1 25.684.0 -155.0

P 119.3 28.169.0 -127.0

P 97.9 22.4 22.0 - 41.0 P 31.6 6.7 30

Colorimetric 22 15.0 - 28.0 P 21.8 2.6 48.0 - 89.0 P 68.5 6.5 66.0 -122.0

P 93.7 10.7 55.0 -101.0

P 78.0 7.5 20.0 - 36.0 P 28.0 3.3 102

Enzymatic/colorimetric 23110.0 -204.0

P 156.8 89.4394.0 -732.0

P 562.8 430.7559.0 -1038.0

P 798.1 627.3446.0 -829.0

P 637.7 485.6144.0 -267.0

P 205.2 131.0 183

All other methods 24 18.0 - 34.0 P 26.0 4.3 53.0 - 98.0 P 75.0 8.4 68.0 -125.0

P 96.5 12.5 58.0 -107.0

P 82.6 9.7 23.0 - 42.0 P 32.4 4.5 20

Total Population

Whole Population 25 63.0 -117.0

P 90.4 6.6 235.0 -436.0

P 335.3 65.6 325.0 -604.0

P 464.6 81.5 267.0 -496.0

P 381.5 68.8 81.0 -150.0

P 115.7 10.3 342

Magnesium mg/dLInitial Grouping by Reagent and Instrument

Abbott Arsenazo & AbbottArchitect c, ci, i

1 2.1 - 3.6 P 2.86 0.08 2.8 - 4.6 P 3.72 0.13 2.6 - 4.3 P 3.42 0.16 1.7 - 2.8 P 2.20 0.10 1.6 - 2.6 P 2.07 0.08 12

Alfa Wassermann & Alfa WasserACE/Centr/Alera

2 2.0 - 3.3 P 2.63 0.18 2.5 - 4.2 P 3.38 0.24 2.3 - 3.8 P 3.08 0.23 1.5 - 2.4 P 1.95 0.14 1.4 - 2.4 P 1.92 0.11 22

Beckman & Beckman SynchronCX3/7/9/L

3 2.2 - 3.7 P 2.92 0.13 2.9 - 4.8 P 3.80 0.12 2.6 - 4.3 P 3.45 0.13 1.7 - 2.8 P 2.21 0.11 1.6 - 2.7 P 2.15 0.09 22

Beckman & Beckman Unicel DXCseries

4 2.2 - 3.6 P 2.91 0.09 2.8 - 4.7 P 3.77 0.10 2.6 - 4.3 P 3.40 0.11 1.6 - 2.7 P 2.19 0.09 1.6 - 2.7 P 2.13 0.05 58

Carolina & Beckman SynchronCX3/7/9/L

5 2.2 - 3.6 P 2.87 0.13 2.8 - 4.7 P 3.75 0.15 2.6 - 4.3 P 3.41 0.17 1.7 - 2.8 P 2.27 0.11 1.6 - 2.7 P 2.15 0.11 14

J&J Vitros & J&J Vitros not DT orECi

6 2.3 - 3.9 P 3.09 0.11 3.0 - 4.9 P 3.94 0.12 2.6 - 4.4 P 3.48 0.11 1.6 - 2.7 P 2.15 0.11 1.6 - 2.7 P 2.17 0.10 51

J&J Vitros & J&J Vitros 5,1 FS 7 2.3 - 3.9 P 3.09 0.13 3.0 - 5.0 P 3.96 0.17 2.6 - 4.4 P 3.49 0.15 1.6 - 2.7 P 2.12 0.11 1.6 - 2.7 P 2.16 0.13 16

Beckman Olymp Xylidyl Blue &Beck Oly AU 400/600/5400

8 2.1 - 3.5 P 2.81 0.13 2.8 - 4.6 P 3.67 0.12 2.4 - 4.1 P 3.26 0.12 1.6 - 2.6 P 2.07 0.10 1.5 - 2.5 P 2.01 0.07 25

Roche Cobas & Roche CobasIntegra

9 2.1 - 3.6 P 2.86 0.10 2.7 - 4.5 P 3.64 0.11 2.4 - 4.1 P 3.25 0.11 1.6 - 2.7 P 2.13 0.08 1.6 - 2.6 P 2.10 0.09 18

Siemens & Siemens Advia series 10 2.2 - 3.7 P 2.95 0.14 2.8 - 4.6 P 3.71 0.17 2.5 - 4.2 P 3.33 0.15 1.6 - 2.7 P 2.19 0.11 1.7 - 2.8 P 2.21 0.13 15

Siemens Dimension & SiemensDimension series

11 2.1 - 3.5 P 2.77 0.09 2.7 - 4.6 P 3.66 0.10 2.4 - 4.1 P 3.26 0.09 1.5 - 2.5 P 1.97 0.06 1.4 - 2.4 P 1.93 0.09 53

Siemens Dimension & SiemensDimension EXL

12 2.1 - 3.4 P 2.76 0.10 2.8 - 4.6 P 3.68 0.07 2.4 - 4.1 P 3.26 0.10 1.5 - 2.5 P 1.97 0.08 1.4 - 2.4 P 1.93 0.08 18

Siemens Dimension & Siemens

Page 19: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Dimension Rxl 13 2.1 - 3.5 P 2.78 0.04 2.7 - 4.6 P 3.66 0.07 2.4 - 4.1 P 3.27 0.06 1.5 - 2.5 P 1.98 0.06 1.5 - 2.4 P 1.96 0.05 15

Siemens Dimension & SiemensDimension Xpand

14 2.1 - 3.4 P 2.76 0.08 2.7 - 4.6 P 3.66 0.10 2.4 - 4.1 P 3.26 0.10 1.5 - 2.5 P 1.98 0.08 1.5 - 2.4 P 1.95 0.08 78

Initial Grouping by Reagent

Abbott Arsenazo 15 2.1 - 3.6 P 2.86 0.08 2.8 - 4.6 P 3.72 0.13 2.6 - 4.3 P 3.42 0.16 1.7 - 2.8 P 2.20 0.10 1.6 - 2.6 P 2.07 0.08 12

Alfa Wassermann 16 2.0 - 3.3 P 2.63 0.18 2.5 - 4.2 P 3.38 0.24 2.3 - 3.8 P 3.08 0.23 1.5 - 2.4 P 1.95 0.14 1.4 - 2.4 P 1.92 0.11 22

Beckman 17 2.2 - 3.6 P 2.91 0.10 2.8 - 4.7 P 3.78 0.12 2.6 - 4.3 P 3.42 0.12 1.6 - 2.7 P 2.20 0.09 1.6 - 2.7 P 2.14 0.07 95

Carolina 18 2.1 - 3.5 P 2.77 0.26 2.7 - 4.5 P 3.60 0.35 2.5 - 4.1 P 3.30 0.30 1.7 - 2.8 P 2.22 0.18 1.6 - 2.6 P 2.07 0.20 23

DCL/Genzyme 19 2.0 - 3.4 P 2.71 0.18 2.6 - 4.4 P 3.48 0.23 2.4 - 3.9 P 3.14 0.21 1.6 - 2.6 P 2.09 0.20 1.5 - 2.5 P 2.03 0.22 17

J&J Vitros 20 2.3 - 3.9 P 3.09 0.11 3.0 - 4.9 P 3.95 0.13 2.6 - 4.4 P 3.49 0.13 1.6 - 2.7 P 2.14 0.11 1.6 - 2.7 P 2.17 0.11 73

Beckman Olymp Xylidyl Blue 21 2.1 - 3.5 P 2.80 0.13 2.7 - 4.6 P 3.66 0.13 2.4 - 4.1 P 3.26 0.12 1.6 - 2.6 P 2.07 0.09 1.5 - 2.5 P 2.01 0.08 29

Roche Cobas 22 2.1 - 3.6 P 2.86 0.10 2.7 - 4.5 P 3.64 0.11 2.4 - 4.1 P 3.25 0.11 1.6 - 2.7 P 2.13 0.08 1.6 - 2.6 P 2.10 0.09 32

Siemens 23 2.2 - 3.7 P 2.95 0.14 2.8 - 4.6 P 3.71 0.17 2.5 - 4.2 P 3.33 0.15 1.6 - 2.7 P 2.19 0.11 1.7 - 2.8 P 2.21 0.13 15

Siemens Dimension 24 2.1 - 3.5 P 2.77 0.09 2.7 - 4.6 P 3.66 0.09 2.4 - 4.1 P 3.26 0.09 1.5 - 2.5 P 1.97 0.07 1.5 - 2.4 P 1.94 0.08 164

Initial Grouping by Sensitivity or Principle

Arsenazo 25 2.1 - 3.5 P 2.80 0.21 2.7 - 4.5 P 3.64 0.28 2.5 - 4.2 P 3.34 0.26 1.7 - 2.8 P 2.22 0.15 1.6 - 2.6 P 2.08 0.16 37

Calmagite-based 26 2.2 - 3.6 P 2.90 0.11 2.8 - 4.7 P 3.76 0.15 2.6 - 4.3 P 3.41 0.14 1.6 - 2.7 P 2.18 0.11 1.6 - 2.7 P 2.12 0.10 102

Magon (Xylidyl Blue)-based 27 2.1 - 3.5 P 2.80 0.21 2.7 - 4.5 P 3.58 0.24 2.4 - 4.0 P 3.23 0.20 1.6 - 2.6 P 2.08 0.16 1.5 - 2.6 P 2.05 0.17 117

MTB (methylthymol blue) 28 2.1 - 3.5 P 2.77 0.09 2.7 - 4.6 P 3.66 0.09 2.4 - 4.1 P 3.26 0.09 1.5 - 2.5 P 1.97 0.07 1.5 - 2.4 P 1.94 0.08 164

All other methods 29 2.3 - 3.8 P 3.02 0.15 2.9 - 4.8 P 3.86 0.19 2.6 - 4.3 P 3.42 0.16 1.6 - 2.7 P 2.14 0.10 1.6 - 2.7 P 2.15 0.11 106

Total Population

Whole Population 30 2.1 - 3.6 P 2.86 0.18 2.8 - 4.6 P 3.70 0.21 2.5 - 4.2 P 3.32 0.18 1.6 - 2.6 P 2.09 0.15 1.5 - 2.6 P 2.05 0.15 542

Magnesium mEq/LInitial Grouping by Sensitivity or Principle

Magon (Xylidyl Blue)-based 1 1.8 - 3.1 P 2.47 0.28 2.4 - 3.9 P 3.14 0.37 2.1 - 3.6 P 2.84 0.33 1.4 - 2.3 P 1.86 0.23 1.4 - 2.3 P 1.82 0.23 41

Total Population

Whole Population 2 1.8 - 3.0 P 2.43 0.26 2.3 - 3.9 P 3.08 0.34 2.1 - 3.5 P 2.79 0.32 1.4 - 2.3 P 1.82 0.22 1.3 - 2.2 P 1.77 0.20 67

Thyroid Stimulating HormoneInitial Grouping by Reagent and Instrument

Abbott CMIA & Abbott Architect c,ci, i

1 1.5 - 1.9 S 1.66 0.07 5.2 - 6.6 S 5.93 0.23 7.9 - 9.4 S 8.66 0.25 6.0 - 8.1 S 7.05 0.36 2.0 - 2.6 S 2.32 0.09 12

Abbott MEIA & Abbott AxSYM 2 1.2 - 2.3 S 1.77 0.19 4.3 - 7.9 S 6.07 0.61 6.2 - 11.3 S 8.74 0.86 5.4 - 9.2 S 7.32 0.64 1.7 - 3.3 S 2.47 0.26 53

Abbott MEIA & Abbott IMx 3 1.5 - 2.2 S 1.84 0.10 5.1 - 7.3 S 6.20 0.38 7.3 - 11.2 S 9.28 0.65 6.6 - 8.7 S 7.62 0.35 2.1 - 3.0 S 2.56 0.14 27

Beckman Access & BeckmanAccess luminometer

4 1.4 - 2.1 S 1.76 0.11 5.0 - 7.0 S 6.02 0.34 7.0 - 10.0 S 8.49 0.50 5.9 - 8.3 S 7.06 0.40 2.0 - 2.8 S 2.42 0.14 121

bioMerieux Vidas & bioMerieuxmini Vidas/Vidas

5 1.7 - 2.6 S 2.12 0.14 5.9 - 9.3 S 7.59 0.57 8.5 - 13.3 S 10.89 0.80 7.0 - 10.9 S 8.97 0.65 2.3 - 3.6 S 2.94 0.21 66

Dade Behring & Siemens

Page 20: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Dimension series 6 1.5 - 2.3 S 1.91 0.14 4.9 - 7.9 S 6.40 0.48 7.1 - 11.7 S 9.42 0.77 6.1 - 9.6 S 7.84 0.58 2.0 - 3.2 S 2.62 0.20 52

Dade Behring & SiemensDimension Xpand

7 1.6 - 2.2 S 1.90 0.10 5.1 - 8.0 S 6.57 0.48 7.3 - 11.7 S 9.51 0.75 6.9 - 9.1 S 7.98 0.37 2.2 - 3.1 S 2.69 0.15 32

DiaSorin CTK-3 & All gammacounters

8 1.4 - 3.6 S 2.52 0.36 4.2 - 12.1 S 8.17 1.31 6.9 - 16.1 S 11.49 1.55 5.4 - 14.3 S 9.84 1.47 2.0 - 5.1 S 3.53 0.52 34

DiaSorin GammaCoat & Allgamma counters

9 1.6 - 3.7 S 2.64 0.36 4.0 - 12.5 S 8.25 1.41 6.0 - 17.3 S 11.68 1.88 5.2 - 14.7 S 9.96 1.59 2.4 - 4.8 S 3.59 0.41 13

J&J Vitros & J&J Vitros ECi 10 2.3 - 2.8 S 2.56 0.09 8.0 - 10.1 S 9.06 0.34 11.5 - 13.7 S 12.61 0.38 9.2 - 11.7 S 10.42 0.42 3.2 - 3.8 S 3.52 0.11 20

Roche Elecsys & Roche Elecsysseries

11 1.9 - 2.4 S 2.14 0.08 6.1 - 7.7 S 6.89 0.28 8.1 - 10.8 S 9.44 0.44 6.8 - 9.0 S 7.90 0.38 2.5 - 3.3 S 2.89 0.12 29

Siemens Coat-A-Count IRMA &All gamma counters

12 1.3 - 2.5 S 1.89 0.21 4.7 - 8.7 S 6.71 0.67 8.3 - 12.8 S 10.53 0.76 6.3 - 10.1 S 8.21 0.64 1.6 - 3.5 S 2.52 0.32 27

Siemens ADVIA Centaur/IMS &Siemens Centaur/Centaur CP

13 1.8 - 2.6 S 2.22 0.13 6.2 - 8.9 S 7.53 0.46 8.0 - 13.3 S 10.60 0.88 7.8 - 10.3 S 9.08 0.42 2.3 - 3.8 S 3.04 0.25 24

Siemens Dimension & SiemensDimension series

14 1.5 - 2.2 S 1.88 0.12 5.2 - 7.7 S 6.43 0.41 7.6 - 11.3 S 9.44 0.62 6.0 - 9.6 S 7.79 0.61 2.1 - 3.2 S 2.63 0.18 14

Siemens Dimension & SiemensDimension Xpand

15 1.5 - 2.2 S 1.86 0.12 4.9 - 7.8 S 6.37 0.48 7.3 - 11.1 S 9.22 0.63 6.0 - 9.5 S 7.75 0.60 2.2 - 3.0 S 2.61 0.14 44

Siemens Immulite (3rd gen) &Siemens Immulite/Immul 1000

16 1.4 - 2.3 S 1.88 0.15 5.2 - 8.0 S 6.61 0.47 7.1 - 11.4 S 9.29 0.71 6.5 - 9.7 S 8.10 0.55 2.0 - 3.2 S 2.60 0.21 46

Siemens Immulite (3rd gen) &Siemens Immulite 2000

17 1.5 - 2.3 S 1.90 0.14 5.3 - 7.9 S 6.59 0.43 7.3 - 11.5 S 9.44 0.70 6.4 - 9.6 S 7.98 0.53 2.2 - 3.2 S 2.68 0.17 29

Siemens Immulite (rapid) &Siemens Immulite/Immul 1000

18 1.6 - 2.4 S 1.99 0.14 5.2 - 7.9 S 6.58 0.45 7.6 - 11.2 S 9.38 0.61 6.7 - 9.3 S 7.99 0.44 2.4 - 3.2 S 2.82 0.13 17

Siemens Immulite (rapid) &Siemens Immulite 2000

19 1.5 - 2.3 S 1.91 0.13 5.4 - 7.7 S 6.55 0.37 7.3 - 11.5 S 9.36 0.70 6.5 - 9.2 S 7.83 0.45 2.2 - 3.3 S 2.76 0.19 24

Tosoh AIA & Tosoh Medics AIA 20 1.8 - 2.6 S 2.24 0.14 5.9 - 9.4 S 7.65 0.59 9.0 - 12.8 S 10.89 0.64 7.4 - 10.8 S 9.08 0.56 2.4 - 3.9 S 3.13 0.25 38

Tosoh AIA & Tosoh Medics STAIA

21 1.8 - 2.7 S 2.26 0.15 6.0 - 9.4 S 7.72 0.57 8.8 - 12.8 S 10.83 0.66 7.1 - 10.8 S 8.92 0.61 2.5 - 3.7 S 3.11 0.21 38

Initial Grouping by Reagent

Abbott CMIA 22 1.5 - 1.9 S 1.66 0.07 5.2 - 6.6 S 5.93 0.23 7.9 - 9.4 S 8.66 0.25 6.0 - 8.1 S 7.05 0.36 2.0 - 2.6 S 2.32 0.09 12

Abbott MEIA 23 1.3 - 2.3 S 1.80 0.17 4.5 - 7.7 S 6.12 0.54 6.4 - 11.4 S 8.92 0.83 5.7 - 9.1 S 7.42 0.57 1.8 - 3.2 S 2.50 0.23 80

Beckman Access 24 1.4 - 2.1 S 1.76 0.11 5.0 - 7.1 S 6.04 0.35 7.0 - 10.0 S 8.51 0.50 5.9 - 8.3 S 7.08 0.41 2.0 - 2.8 S 2.42 0.14 132

bioMerieux Vidas 25 1.7 - 2.6 S 2.12 0.14 5.9 - 9.3 S 7.59 0.57 8.5 - 13.3 S 10.89 0.80 7.0 - 10.9 S 8.97 0.65 2.3 - 3.6 S 2.94 0.21 66

Dade Behring 26 1.5 - 2.3 S 1.90 0.13 5.0 - 7.9 S 6.45 0.48 7.2 - 11.7 S 9.43 0.75 6.3 - 9.4 S 7.87 0.51 2.1 - 3.2 S 2.64 0.18 96

DiaSorin CTK-3 27 1.4 - 3.6 S 2.49 0.37 4.2 - 12.1 S 8.14 1.30 6.8 - 16.0 S 11.43 1.53 5.4 - 14.2 S 9.81 1.46 2.0 - 5.0 S 3.51 0.51 36

DiaSorin GammaCoat 28 1.9 - 3.3 S 2.59 0.24 4.2 - 12.2 S 8.20 1.34 6.2 - 17.1 S 11.67 1.82 5.2 - 14.7 S 9.95 1.57 2.4 - 4.7 S 3.59 0.39 15

J&J Vitros 29 2.3 - 2.8 S 2.54 0.08 8.1 - 10.0 S 9.07 0.32 11.5 - 13.8 S 12.65 0.37 9.3 - 11.7 S 10.46 0.40 3.2 - 3.8 S 3.51 0.11 25

Roche Elecsys 30 1.9 - 2.4 S 2.16 0.10 6.0 - 7.8 S 6.93 0.30 8.1 - 10.9 S 9.51 0.47 6.7 - 9.2 S 7.92 0.41 2.5 - 3.3 S 2.90 0.13 44

Siemens Coat-A-Count IRMA 31 1.3 - 2.5 S 1.89 0.21 4.7 - 8.7 S 6.71 0.67 8.3 - 12.8 S 10.53 0.76 6.3 - 10.1 S 8.21 0.64 1.6 - 3.5 S 2.52 0.32 27

Siemens ADVIA Centaur/IMS 32 1.7 - 2.7 S 2.19 0.16 5.9 - 9.0 S 7.44 0.52 7.7 - 13.2 S 10.47 0.91 7.3 - 10.6 S 8.95 0.56 2.2 - 3.8 S 3.00 0.27 29

Siemens Dimension 33 1.5 - 2.2 S 1.87 0.12 5.0 - 7.8 S 6.39 0.46 7.2 - 11.3 S 9.25 0.67 6.0 - 9.6 S 7.76 0.60 2.1 - 3.1 S 2.61 0.16 74

Siemens Immulite (3rd gen) 34 1.4 - 2.3 S 1.89 0.15 5.2 - 8.0 S 6.62 0.46 7.2 - 11.5 S 9.38 0.71 6.4 - 9.8 S 8.07 0.56 2.1 - 3.2 S 2.64 0.19 81

Page 21: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Siemens Immulite (rapid) 35 1.5 - 2.4 S 1.94 0.14 5.4 - 7.8 S 6.57 0.40 7.4 - 11.3 S 9.37 0.66 6.6 - 9.2 S 7.90 0.45 2.3 - 3.3 S 2.78 0.17 41

Tosoh AIA 36 1.8 - 2.7 S 2.25 0.14 5.9 - 9.4 S 7.68 0.59 8.8 - 12.9 S 10.87 0.69 7.1 - 10.9 S 9.01 0.64 2.4 - 3.9 S 3.12 0.24 81

Initial Grouping by Sensitivity or Principle

Low recovery methods 37 1.4 - 2.1 S 1.76 0.11 5.0 - 7.1 S 6.04 0.35 7.0 - 10.0 S 8.51 0.50 5.9 - 8.3 S 7.08 0.41 2.0 - 2.8 S 2.42 0.14 132

Low moderate recovery meths 38 1.2 - 2.6 S 1.93 0.23 4.3 - 8.8 S 6.56 0.76 6.4 - 12.7 S 9.53 1.05 5.3 - 10.7 S 7.97 0.90 1.7 - 3.7 S 2.69 0.33 191

Moderate recovery methods 39 1.3 - 2.7 S 1.99 0.23 4.4 - 9.3 S 6.82 0.81 6.4 - 13.3 S 9.84 1.14 5.4 - 10.8 S 8.11 0.90 1.8 - 3.7 S 2.73 0.32 260

High moderate recovery meth 40 1.2 - 3.0 S 2.11 0.30 4.4 - 10.0 S 7.20 0.92 6.5 - 13.9 S 10.20 1.22 5.6 - 11.7 S 8.63 1.03 1.7 - 4.2 S 2.96 0.42 240

All other methods 41 2.3 - 2.8 S 2.54 0.08 8.1 - 10.0 S 9.07 0.32 11.5 - 13.8 S 12.65 0.37 9.3 - 11.7 S 10.46 0.40 3.2 - 3.8 S 3.51 0.11 25

Total Population

Whole Population 42 1.2 - 2.7 S 1.97 0.25 4.2 - 9.4 S 6.77 0.87 6.0 - 13.4 S 9.71 1.24 5.1 - 11.1 S 8.09 1.01 1.7 - 3.8 S 2.73 0.35 861

Thyroxine, Free (FT4)Initial Grouping by Reagent and Instrument

Abbott CMIA & Abbott Architect c,ci, i

1 1.6 - 2.6 S 2.12 0.17 3.7 - 5.9 S 4.82 0.36 5.5 - 6.5 S 6.00 0.17 4.1 - 6.9 S 5.51 0.46 1.9 - 3.3 S 2.60 0.23 10

Abbott MEIA & Abbott AxSYM 2 1.0 - 1.4 S 1.19 0.07 2.2 - 3.3 S 2.72 0.19 2.6 - 3.8 S 3.21 0.20 2.0 - 3.0 S 2.49 0.16 1.0 - 1.5 S 1.29 0.08 40

Beckman Access & BeckmanAccess luminometer

3 1.3 - 2.1 S 1.72 0.13 2.5 - 3.7 S 3.09 0.20 2.8 - 4.4 S 3.60 0.26 2.5 - 3.9 S 3.24 0.23 1.5 - 2.4 S 1.96 0.15 101

bioMerieux Vidas & bioMerieuxmini Vidas/Vidas

4 1.0 - 1.5 S 1.24 0.08 2.2 - 3.2 S 2.70 0.18 2.7 - 4.2 S 3.48 0.25 2.3 - 3.7 S 3.00 0.23 1.2 - 1.8 S 1.47 0.10 48

Dade Behring & SiemensDimension series

5 1.5 - 3.4 S 2.49 0.32 3.1 - 6.1 S 4.61 0.50 3.8 - 6.7 S 5.26 0.49 3.2 - 6.4 S 4.80 0.53 1.7 - 4.1 S 2.90 0.40 31

Dade Behring & SiemensDimension Xpand

6 1.3 - 3.7 S 2.52 0.40 2.6 - 6.6 S 4.61 0.67 3.4 - 7.0 S 5.24 0.60 3.0 - 6.9 S 4.93 0.66 1.6 - 4.1 S 2.86 0.41 21

DiaSorin GammaCoat 1-Step & Allgamma counters

7 0.3 - 1.3 S 0.82 0.16 1.4 - 3.0 S 2.20 0.28 2.0 - 4.2 S 3.11 0.36 2.0 - 3.8 S 2.88 0.29 0.5 - 1.6 S 1.05 0.17 46

J&J Vitros & J&J Vitros ECi 8 4.6 - 5.9 S 5.22 0.22 6.8 - 7.1 S 6.94 0.05 6.8 - 7.1 S 6.94 0.05 6.8 - 7.1 S 6.94 0.05 5.1 - 6.4 S 5.77 0.21 20

Roche Elecsys & Roche Elecsysseries

9 1.7 - 2.5 S 2.07 0.13 3.1 - 5.0 S 4.07 0.32 4.1 - 6.9 S 5.47 0.46 3.6 - 5.9 S 4.71 0.39 1.9 - 2.9 S 2.40 0.17 23

Siemens Coat-A-Count & Allgamma counters

10 0.3 - 0.9 S 0.63 0.10 1.0 - 2.4 S 1.71 0.24 1.5 - 3.3 S 2.40 0.30 1.2 - 2.9 S 2.07 0.28 0.4 - 1.2 S 0.80 0.13 27

Siemens ADVIA Centaur/IMS &Siemens Centaur/Centaur CP

11 1.4 - 2.1 S 1.74 0.11 2.4 - 4.4 S 3.42 0.34 2.9 - 5.4 S 4.12 0.41 2.4 - 4.8 S 3.62 0.40 1.5 - 2.5 S 1.98 0.16 20

Siemens Dimension & SiemensDimension series

12 1.4 - 3.7 S 2.53 0.38 3.1 - 6.4 S 4.78 0.55 3.4 - 7.2 S 5.31 0.63 3.1 - 7.3 S 5.21 0.71 1.5 - 4.5 S 3.03 0.49 10

Siemens Dimension & SiemensDimension Xpand

13 1.3 - 3.6 S 2.44 0.37 3.1 - 5.9 S 4.48 0.47 3.4 - 6.7 S 5.05 0.54 3.4 - 6.3 S 4.83 0.48 2.0 - 3.8 S 2.89 0.30 26

Siemens Immulite (1-step) &Siemens Immulite/Immul 1000

14 6.1 - 6.1 S 6.10 0.00 3.1 - 4.9 S 4.00 0.29 4.0 - 6.1 S 5.05 0.35 3.5 - 5.3 S 4.40 0.31 2.2 - 2.9 S 2.54 0.12 23

Siemens Immulite (1-step) &Siemens Immulite 2000

15 0.9 - 3.3 S 2.12 0.40 2.4 - 5.3 S 3.87 0.48 4.3 - 5.7 S 4.99 0.24 2.9 - 5.5 S 4.21 0.44 1.2 - 3.6 S 2.40 0.39 21

Siemens Immulite (analog) &Siemens Immulite 2000

16 2.0 - 2.6 S 2.31 0.10 3.4 - 4.7 S 4.05 0.23 4.3 - 5.6 S 4.99 0.22 3.3 - 5.4 S 4.36 0.34 2.1 - 3.2 S 2.62 0.18 17

Page 22: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Tosoh AIA & Tosoh Medics AIA 17 1.7 - 3.2 S 2.47 0.25 3.9 - 6.1 S 4.99 0.37 5.5 - 7.1 S 6.31 0.27 4.5 - 6.3 S 5.42 0.30 2.2 - 3.4 S 2.80 0.21 21

Tosoh AIA & Tosoh Medics STAIA

18 2.1 - 2.9 S 2.53 0.14 4.5 - 5.8 S 5.14 0.23 5.7 - 7.0 S 6.31 0.22 4.5 - 6.3 S 5.42 0.30 2.5 - 3.2 S 2.82 0.12 25

Initial Grouping by Reagent

Abbott CMIA 19 1.6 - 2.6 S 2.12 0.17 3.7 - 5.9 S 4.82 0.36 5.7 - 6.2 S 5.95 0.08 4.1 - 6.9 S 5.51 0.46 1.9 - 3.3 S 2.60 0.23 10

Abbott MEIA 20 1.0 - 1.4 S 1.19 0.07 2.1 - 3.3 S 2.70 0.20 2.5 - 3.8 S 3.19 0.22 2.0 - 3.0 S 2.50 0.16 1.0 - 1.5 S 1.29 0.09 49

Beckman Access 21 1.3 - 2.1 S 1.71 0.13 2.5 - 3.7 S 3.09 0.19 2.8 - 4.4 S 3.61 0.27 2.5 - 4.0 S 3.25 0.23 1.5 - 2.4 S 1.96 0.14 108

bioMerieux Vidas 22 1.0 - 1.5 S 1.24 0.08 2.2 - 3.2 S 2.70 0.18 2.7 - 4.2 S 3.48 0.25 2.3 - 3.7 S 3.00 0.23 1.2 - 1.8 S 1.47 0.10 48

Dade Behring 23 1.5 - 3.6 S 2.52 0.35 3.0 - 6.3 S 4.61 0.55 3.7 - 6.8 S 5.24 0.51 3.2 - 6.5 S 4.86 0.56 1.7 - 4.1 S 2.90 0.39 57

DiaSorin GammaCoat 1-Step 24 0.3 - 1.3 S 0.81 0.16 1.4 - 3.0 S 2.20 0.27 2.0 - 4.2 S 3.10 0.37 2.0 - 3.7 S 2.89 0.29 0.6 - 1.5 S 1.05 0.17 50

J&J Vitros 25 4.4 - 5.9 S 5.18 0.25 6.8 - 7.1 S 6.94 0.05 6.8 - 7.1 S 6.94 0.05 6.8 - 7.1 S 6.94 0.05 5.1 - 6.4 S 5.73 0.22 25

Roche Elecsys 26 1.7 - 2.5 S 2.08 0.13 3.1 - 5.1 S 4.11 0.33 4.3 - 6.7 S 5.49 0.41 3.6 - 5.7 S 4.68 0.35 1.9 - 2.9 S 2.39 0.16 38

Siemens Coat-A-Count 27 0.3 - 0.9 S 0.63 0.10 1.0 - 2.4 S 1.71 0.24 1.5 - 3.3 S 2.40 0.30 1.2 - 2.9 S 2.07 0.28 0.4 - 1.2 S 0.80 0.13 27

Siemens ADVIA Centaur/IMS 28 1.4 - 2.1 S 1.73 0.12 2.4 - 4.4 S 3.40 0.34 2.9 - 5.3 S 4.13 0.40 2.4 - 4.9 S 3.63 0.41 1.5 - 2.5 S 1.97 0.16 24

Siemens Dimension 29 1.3 - 3.6 S 2.44 0.39 3.0 - 6.2 S 4.61 0.53 3.3 - 7.0 S 5.18 0.62 3.2 - 6.7 S 4.93 0.59 1.8 - 4.0 S 2.89 0.36 48

Siemens Immulite (1-step) 30 0.9 - 3.3 S 2.12 0.39 2.7 - 5.1 S 3.93 0.39 4.1 - 5.9 S 5.02 0.31 3.2 - 5.5 S 4.31 0.39 1.6 - 3.3 S 2.47 0.29 45

Siemens Immulite (analog) 31 2.0 - 2.6 S 2.31 0.10 3.5 - 4.7 S 4.09 0.21 4.4 - 5.6 S 5.03 0.20 3.5 - 5.3 S 4.41 0.29 2.1 - 3.1 S 2.62 0.16 29

Tosoh AIA 32 1.9 - 3.1 S 2.49 0.20 4.1 - 6.1 S 5.08 0.33 5.5 - 7.1 S 6.29 0.26 4.5 - 6.3 S 5.40 0.31 2.3 - 3.3 S 2.80 0.16 51

Initial Grouping by Sensitivity or Principle

Low recovery methods 33 0.6 - 2.2 S 1.41 0.26 1.7 - 4.2 S 2.95 0.41 2.4 - 5.0 S 3.70 0.44 1.9 - 4.5 S 3.22 0.43 0.8 - 2.4 S 1.64 0.27 72

Low moderate recovery meth 34 1.2 - 3.6 S 2.39 0.40 3.0 - 6.2 S 4.60 0.54 3.1 - 7.4 S 5.26 0.72 3.1 - 6.8 S 4.94 0.61 1.7 - 4.0 S 2.83 0.38 54

Moderate recovery methods 35 0.0 - 3.7 S 1.72 0.67 0.1 - 6.8 S 3.46 1.12 0.3 - 8.1 S 4.22 1.29 0.2 - 7.3 S 3.75 1.17 0.0 - 4.2 S 1.98 0.74 390

High moderate recovery meth 36 1.4 - 3.1 S 2.23 0.29 3.0 - 5.0 S 3.99 0.34 4.2 - 5.8 S 5.03 0.27 3.3 - 5.4 S 4.35 0.35 1.8 - 3.3 S 2.53 0.26 74

High recovery methods 37 3.1 - 7.0 S 5.06 0.65 5.5 - 8.2 S 6.85 0.46 5.6 - 8.1 S 6.86 0.42 5.3 - 8.4 S 6.85 0.50 3.4 - 7.7 S 5.59 0.72 26

Total Population

Whole Population 38 0.9 - 3.1 S 2.00 0.38 1.4 - 5.9 S 3.63 0.76 1.5 - 7.1 S 4.30 0.93 1.4 - 6.5 S 3.96 0.84 1.1 - 3.6 S 2.32 0.42 623

Thyroxine, Total (TT4)Initial Grouping by Reagent and Instrument

Abbott FPIA & Abbott AxSYM 1 4.3 - 6.5 P 5.41 0.64 8.7 - 13.0 P 10.87 0.54 11.8 - 17.7 P 14.75 0.60 10.2 - 15.4 P 12.80 0.44 5.2 - 7.7 P 6.45 0.44 26

Abbott FPIA & Abbott IMx 2 4.3 - 6.4 P 5.32 0.42 8.6 - 12.9 P 10.71 0.71 11.5 - 17.2 P 14.35 0.93 10.1 - 15.1 P 12.59 0.71 4.9 - 7.4 P 6.18 0.52 13

Beckman Access & BeckmanAccess luminometer

3 5.4 - 8.1 P 6.72 0.47 10.7 - 16.0 P 13.32 0.92 13.2 - 19.9 P 16.55 1.03 11.4 - 17.2 P 14.30 1.03 6.2 - 9.3 P 7.76 0.57 68

bioMerieux Vidas & bioMerieuxmini Vidas/Vidas

4 5.0 - 7.5 P 6.26 0.46 9.1 - 13.7 P 11.38 0.51 11.0 - 16.5 P 13.76 0.98 9.8 - 14.7 P 12.22 0.74 5.7 - 8.6 P 7.12 0.28 16

J&J Vitros & J&J Vitros ECi 5 4.8 - 7.2 P 6.00 0.25 11.3 - 16.9 P 14.09 0.43 15.5 - 23.2 P 19.37 0.87 13.8 - 20.7 P 17.29 1.23 6.1 - 9.2 P 7.68 0.48 10

Roche Elecsys & Roche Elecsysseries

6 4.0 - 6.0 C 4.95 0.24 8.5 - 12.7 P 10.59 0.57 11.5 - 17.3 P 14.43 0.67 10.1 - 15.2 P 12.64 0.87 4.8 - 7.2 P 6.02 0.29 10

Siemens ADVIA Centaur/IMS &Siemens Centaur/Centaur CP

7 4.1 - 6.2 P 5.15 0.30 8.7 - 13.1 P 10.90 0.60 11.0 - 16.5 P 13.72 0.69 9.9 - 14.9 P 12.42 0.58 5.0 - 7.6 P 6.30 0.32 20

Siemens Dimension & Siemens

Page 23: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Dimension series 8 4.7 - 7.0 P 5.85 0.58 9.6 - 14.4 P 11.99 0.64 13.2 - 19.8 P 16.51 0.69 11.4 - 17.1 P 14.23 0.76 5.5 - 8.2 P 6.81 0.56 21

Siemens Dimension & SiemensDimension Rxl

9 4.7 - 7.0 P 5.83 0.53 9.7 - 14.5 P 12.09 0.47 13.1 - 19.7 P 16.38 0.83 11.7 - 17.5 P 14.60 0.44 5.4 - 8.1 P 6.76 0.44 10

Siemens Dimension & SiemensDimension Xpand

10 4.7 - 7.0 P 5.84 0.56 9.8 - 14.7 P 12.24 0.61 13.3 - 19.9 P 16.62 0.93 11.6 - 17.4 P 14.48 0.72 5.5 - 8.3 P 6.90 0.47 22

Siemens Immulite & SiemensImmulite/Immul 1000

11 4.4 - 6.6 P 5.52 0.64 10.2 - 15.3 P 12.75 1.48 13.3 - 20.0 P 16.66 1.69 12.0 - 18.0 P 14.98 1.82 5.3 - 8.0 P 6.66 0.85 17

Siemens Immulite & SiemensImmulite 2000

12 4.1 - 6.2 P 5.18 0.37 9.3 - 14.0 P 11.67 0.86 12.2 - 18.3 P 15.26 1.26 10.8 - 16.2 P 13.51 0.88 5.1 - 7.6 P 6.35 0.32 26

Tosoh AIA & Tosoh Medics AIA 13 4.9 - 7.3 P 6.06 0.23 10.1 - 15.2 P 12.65 0.56 13.6 - 20.4 P 17.01 1.11 11.7 - 17.6 P 14.66 0.96 5.8 - 8.8 P 7.30 0.66 12

Tosoh AIA & Tosoh Medics STAIA

14 5.0 - 7.5 P 6.24 0.37 10.2 - 15.3 P 12.72 0.78 13.6 - 20.4 P 16.99 0.86 12.1 - 18.1 P 15.10 0.94 5.8 - 8.7 P 7.21 0.43 12

Initial Grouping by Reagent

Abbott FPIA 15 4.3 - 6.5 P 5.38 0.57 8.7 - 13.0 P 10.82 0.60 11.7 - 17.5 P 14.62 0.73 10.2 - 15.3 P 12.74 0.54 5.1 - 7.6 P 6.36 0.48 39

Beckman Access 16 5.4 - 8.1 P 6.74 0.47 10.7 - 16.0 P 13.37 0.92 13.3 - 19.9 P 16.58 1.01 11.5 - 17.2 P 14.36 1.01 6.2 - 9.3 P 7.78 0.58 77

bioMerieux Vidas 17 5.0 - 7.5 P 6.26 0.46 9.1 - 13.7 P 11.38 0.51 11.0 - 16.5 P 13.76 0.98 9.8 - 14.7 P 12.22 0.74 5.7 - 8.6 P 7.12 0.28 16

J&J Vitros 18 4.9 - 7.3 P 6.07 0.26 11.4 - 17.0 P 14.20 0.47 15.6 - 23.3 P 19.44 0.76 13.8 - 20.7 P 17.27 1.07 6.2 - 9.3 P 7.72 0.42 13

Roche Elecsys 19 4.1 - 6.1 P 5.06 0.41 8.5 - 12.8 P 10.66 0.73 11.5 - 17.2 P 14.36 0.82 9.9 - 14.9 P 12.40 1.07 4.8 - 7.2 P 5.99 0.43 17

Siemens ADVIA Centaur/IMS 20 4.1 - 6.1 P 5.11 0.33 8.6 - 13.0 P 10.81 0.67 10.8 - 16.3 P 13.55 0.87 9.9 - 14.9 P 12.40 0.56 5.0 - 7.5 P 6.26 0.36 23

Siemens Dimension 21 4.7 - 7.0 P 5.82 0.55 9.7 - 14.5 P 12.11 0.61 13.2 - 19.8 P 16.51 0.80 11.5 - 17.3 P 14.40 0.71 5.5 - 8.2 P 6.84 0.50 61

Siemens Immulite 22 4.3 - 6.4 P 5.33 0.52 9.7 - 14.5 P 12.12 1.23 12.7 - 19.0 P 15.85 1.55 11.3 - 16.9 P 14.09 1.48 5.2 - 7.8 P 6.52 0.62 45

Tosoh AIA 23 4.9 - 7.4 P 6.14 0.35 10.1 - 15.2 P 12.65 0.65 13.6 - 20.4 P 16.98 0.96 11.9 - 17.8 P 14.86 0.92 5.8 - 8.7 P 7.25 0.53 26

Initial Grouping by Sensitivity or Principle

Low recovery methods 24 4.2 - 6.3 P 5.27 0.48 9.4 - 14.0 P 11.69 1.23 12.1 - 18.1 P 15.10 1.73 10.8 - 16.2 P 13.53 1.47 5.1 - 7.7 P 6.44 0.56 69

Low moderate recovery meths 25 4.6 - 6.9 P 5.79 0.68 9.5 - 14.2 P 11.84 1.54 12.6 - 18.8 P 15.69 2.57 11.0 - 16.5 P 13.72 2.40 5.5 - 8.3 P 6.89 0.81 48

Moderate recovery methods 26 4.6 - 6.9 P 5.77 0.62 9.5 - 14.3 P 11.90 1.10 12.9 - 19.3 P 16.11 1.48 11.3 - 16.9 P 14.07 1.30 5.4 - 8.2 P 6.80 0.61 142

High moderate recovery meth 27 4.1 - 6.2 P 5.18 0.50 9.0 - 13.5 P 11.22 0.99 12.8 - 19.3 P 16.05 1.60 11.0 - 16.5 P 13.77 1.30 5.1 - 7.6 P 6.32 0.67 16

High recovery methods 28 5.4 - 8.1 P 6.74 0.47 10.7 - 16.0 P 13.37 0.92 13.3 - 19.9 P 16.58 1.01 11.5 - 17.2 P 14.36 1.01 6.2 - 9.3 P 7.78 0.58 77

Total Population

Whole Population 29 4.7 - 7.0 P 5.86 0.76 9.7 - 14.6 P 12.14 1.32 12.8 - 19.1 P 15.95 1.70 11.1 - 16.7 P 13.90 1.43 5.5 - 8.3 P 6.93 0.78 362

Triiodothyronine, Total (TT3)Initial Grouping by Reagent and Instrument

Beckman Access & BeckmanAccess luminometer

1 0.77 - 1.26 S 1.015 0.082 1.48 - 2.38 S 1.926 0.150 1.82 - 3.19 S 2.506 0.229 1.64 - 2.69 S 2.163 0.174 0.84 - 1.46 S 1.150 0.104 30

bioMerieux Vidas & bioMerieuxmini Vidas/Vidas

2 0.7 - 1.29 S 0.998 0.099 1.52 - 2.43 S 1.975 0.151 2.0 - 2.87 S 2.431 0.145 1.62 - 2.6 S 2.111 0.162 0.79 - 1.42 S 1.105 0.106 16

DiaSorin GammaCoat & Allgamma counters

3 0.69 - 1.23 S 0.962 0.090 1.66 - 2.59 S 2.124 0.156 2.12 - 4.12 S 3.118 0.334 1.86 - 3.4 S 2.629 0.258 0.86 - 1.62 S 1.242 0.126 36

Roche Elecsys & Roche Elecsysseries

4 0.88 - 1.16 S 1.022 0.046 1.51 - 2.12 S 1.816 0.101 1.91 - 2.6 S 2.254 0.116 1.77 - 2.22 S 1.992 0.075 0.87 - 1.33 S 1.097 0.076 13

Siemens Coat-A-Count & All

Page 24: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

gamma counters 5 0.49 - 1.02 S 0.751 0.088 1.39 - 1.91 S 1.646 0.087 1.8 - 2.38 S 2.092 0.097 1.72 - 1.97 S 1.842 0.042 0.69 - 1.2 S 0.943 0.084 12

Siemens Advia & SiemensCentaur/Centaur CP

6 0.64 - 1.03 S 0.837 0.065 1.24 - 2.32 S 1.780 0.180 1.81 - 2.47 S 2.141 0.109 1.47 - 2.14 S 1.801 0.112 0.72 - 1.18 S 0.953 0.076 15

Siemens Immulite & SiemensImmulite 2000

7 0.4 - 0.79 S 0.596 0.064 1.08 - 1.65 S 1.365 0.096 1.3 - 2.04 S 1.672 0.124 1.18 - 1.63 S 1.405 0.074 0.49 - 0.85 S 0.674 0.060 26

Initial Grouping by Reagent

Abbott MEIA 8 0.36 - 1.34 S 0.851 0.164 1.19 - 2.09 S 1.644 0.150 1.67 - 2.42 S 2.044 0.126 1.26 - 2.25 S 1.755 0.166 0.57 - 1.32 S 0.946 0.126 12

Beckman Access 9 0.76 - 1.29 S 1.023 0.088 1.43 - 2.46 S 1.944 0.172 1.68 - 3.44 S 2.559 0.292 1.63 - 2.71 S 2.171 0.180 0.83 - 1.5 S 1.164 0.112 34

bioMerieux Vidas 10 0.7 - 1.29 S 0.998 0.099 1.52 - 2.43 S 1.975 0.151 2.0 - 2.87 S 2.431 0.145 1.62 - 2.6 S 2.111 0.162 0.79 - 1.42 S 1.105 0.106 16

DiaSorin GammaCoat 11 0.7 - 1.22 S 0.959 0.086 1.66 - 2.58 S 2.121 0.154 2.12 - 4.06 S 3.091 0.324 1.86 - 3.36 S 2.611 0.251 0.87 - 1.6 S 1.237 0.121 41

Roche Elecsys 12 0.88 - 1.18 S 1.030 0.051 1.54 - 2.15 S 1.845 0.103 1.93 - 2.59 S 2.259 0.110 1.69 - 2.28 S 1.982 0.098 0.89 - 1.35 S 1.117 0.077 21

Siemens Coat-A-Count 13 0.49 - 1.02 S 0.751 0.088 1.39 - 1.91 S 1.646 0.087 1.8 - 2.38 S 2.092 0.097 1.72 - 1.97 S 1.842 0.042 0.69 - 1.2 S 0.943 0.084 12

Siemens Advia 14 0.64 - 1.06 S 0.852 0.069 1.46 - 2.01 S 1.734 0.092 1.63 - 2.74 S 2.185 0.186 1.44 - 2.17 S 1.806 0.121 0.73 - 1.19 S 0.961 0.077 19

Siemens Immulite 15 0.43 - 0.77 S 0.603 0.057 1.11 - 1.64 S 1.374 0.089 1.3 - 2.11 S 1.705 0.134 1.17 - 1.64 S 1.409 0.078 0.5 - 0.86 S 0.683 0.060 38

Tosoh AIA 16 0.35 - 6.52 S 3.435 1.0280.52 -10.55

S 5.539 1.6720.68 -12.44

S 6.560 1.960 0.6 - 11.12 S 5.859 1.754 0.35 - 7.17 S 3.760 1.136 12

Initial Grouping by Sensitivity or Principle

Low moderate recovery meths 17 0.27 - 1.36 S 0.814 0.183 0.91 - 2.41 S 1.659 0.249 0.99 - 3.24 S 2.115 0.376 0.84 - 2.73 S 1.782 0.315 0.32 - 1.54 S 0.927 0.203 130

Moderate recovery methods 18 0.69 - 1.24 S 0.965 0.092 1.55 - 2.59 S 2.068 0.174 1.59 - 4.17 S 2.880 0.430 1.46 - 3.46 S 2.457 0.333 0.79 - 1.6 S 1.194 0.135 59

High moderate recovery meth 19 0.82 - 1.26 S 1.044 0.074 1.07 - 2.78 S 1.926 0.286 1.24 - 3.5 S 2.368 0.377 0.98 - 3.2 S 2.088 0.370 0.7 - 1.61 S 1.157 0.151 23

High recovery methods 20 0.35 - 6.52 S 3.435 1.028 0.52 -10.55

S 5.539 1.672 0.68 -12.44

S 6.560 1.960 0.6 - 11.12 S 5.859 1.754 0.35 - 7.17 S 3.760 1.136 12

Total Population

Whole Population 21 0.64 - 1.29 S 0.964 0.107 1.09 - 2.63 S 1.862 0.257 1.1 - 3.8 S 2.449 0.449 1.05 - 3.19 S 2.124 0.357 0.66 - 1.57 S 1.114 0.151 237

T-Uptake % of TotalInitial Grouping by Reagent and Instrument

Beckman Access & BeckmanAccess luminometer

1 38.0 - 58.0 S 47.9 3.4 40.0 - 58.0 S 48.7 3.1 39.0 - 56.0 S 47.7 2.9 39.0 - 53.0 S 46.1 2.4 38.0 - 56.0 S 46.8 3.0 56

Siemens ADVIA Centaur/IMS &Siemens Centaur/Centaur CP

2 37.0 - 62.0 S 49.3 4.1 34.0 - 56.0 S 44.9 3.7 32.0 - 51.0 S 41.7 3.3 31.0 - 50.0 S 40.5 3.3 35.0 - 58.0 S 46.3 3.8 15

Siemens Dimension & SiemensDimension series

3 38.0 - 51.0 S 44.3 2.1 38.0 - 53.0 S 45.5 2.4 42.0 - 51.0 S 46.4 1.5 40.0 - 50.0 S 45.3 1.7 38.0 - 49.0 S 43.5 1.7 15

Siemens Dimension & SiemensDimension Xpand

4 40.0 - 48.0 S 44.0 1.4 41.0 - 50.0 S 45.8 1.4 41.0 - 51.0 S 46.1 1.5 40.0 - 50.0 S 44.6 1.6 39.0 - 47.0 S 43.0 1.4 16

Siemens Immulite & SiemensImmulite/Immul 1000

5 40.0 - 53.0 S 46.7 2.1 44.0 - 52.0 S 48.1 1.3 40.0 - 55.0 S 47.5 2.5 37.0 - 51.0 S 44.4 2.4 37.0 - 53.0 S 45.0 2.7 10

Siemens Immulite & SiemensImmulite 2000

6 35.0 - 52.0 S 43.5 2.8 38.0 - 55.0 S 46.3 2.9 36.0 - 56.0 S 46.2 3.2 35.0 - 53.0 S 43.8 2.9 34.0 - 51.0 S 42.6 2.8 24

Initial Grouping by Reagent

Beckman Access 7 38.0 - 58.0 S 48.0 3.4 40.0 - 58.0 S 48.9 3.1 39.0 - 56.0 S 47.8 2.8 39.0 - 54.0 S 46.4 2.6 38.0 - 56.0 S 47.1 2.9 64

Siemens ADVIA Centaur/IMS 8 37.0 - 63.0 S 49.7 4.3 34.0 - 57.0 S 45.2 3.8 32.0 - 52.0 S 41.9 3.3 31.0 - 51.0 S 40.8 3.3 35.0 - 58.0 S 46.6 3.9 16

Page 25: Alanine Aminotransferase (ALT or SGPT)

Specimen 1 Specimen 2 Specimen 3 Specimen 4 Specimen 5

NameLineNo.

Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SD Range & Type Mean SDNo.ofLabs

Siemens Dimension 9 38.0 - 49.0 S 43.7 1.8 40.0 - 51.0 S 45.4 1.9 40.0 - 52.0 S 46.1 2.0 40.0 - 50.0 S 44.9 1.7 38.0 - 48.0 S 43.1 1.7 45

Siemens Immulite 10 36.0 - 53.0 S 44.6 2.9 39.0 - 55.0 S 47.0 2.8 37.0 - 56.0 S 46.8 3.2 36.0 - 52.0 S 44.1 2.7 35.0 - 52.0 S 43.4 2.9 36

Tosoh AIA 11 43.0 - 49.0 S 46.1 0.9 44.0 - 50.0 S 47.1 1.0 43.0 - 51.0 S 47.1 1.3 43.0 - 49.0 S 45.7 1.0 42.0 - 48.0 S 45.0 0.9 16

Initial Grouping by Sensitivity or Principle

Low moderate recovery meths 12 32.0 - 61.0 S 46.7 4.8 35.0 - 57.0 S 46.0 3.8 30.0 - 59.0 S 44.4 4.9 29.0 - 57.0 S 43.2 4.6 33.0 - 56.0 S 44.8 3.8 33

Moderate recovery methods 13 36.0 - 53.0 S 44.6 2.8 39.0 - 55.0 S 47.1 2.7 38.0 - 56.0 S 47.0 3.1 36.0 - 53.0 S 44.4 2.8 35.0 - 52.0 S 43.6 2.8 40

High moderate recovery meth 14 38.0 - 52.0 S 44.8 2.4 40.0 - 52.0 S 46.1 2.1 41.0 - 52.0 S 46.4 1.8 40.0 - 50.0 S 45.3 1.7 38.0 - 50.0 S 44.0 2.1 66

Very high recovery methods 15 38.0 - 58.0 S 48.0 3.4 40.0 - 58.0 S 48.9 3.1 39.0 - 56.0 S 47.8 2.8 39.0 - 54.0 S 46.4 2.6 38.0 - 56.0 S 47.1 2.9 64

All other methods 16 42.0 - 74.0 S 57.8 5.4 44.0 - 63.0 S 53.1 3.2 40.0 - 56.0 S 48.2 2.7 41.0 - 56.0 S 48.7 2.4 38.0 - 70.0 S 54.0 5.3 10

Total Population

Whole Population 17 34.0 - 59.0 S 46.7 4.3 37.0 - 58.0 S 47.5 3.4 37.0 - 56.0 S 46.7 3.2 36.0 - 55.0 S 45.4 3.2 34.0 - 57.0 S 45.6 3.9 230

T-Uptake Ratio to NormalInitial Grouping by Reagent and Instrument

Abbott FPIA & Abbott AxSYM 1 0.25 - 0.39 S 0.321 0.023 0.36 - 0.51 S 0.431 0.025 0.47 - 0.6 S 0.531 0.022 0.44 - 0.59 S 0.516 0.025 0.29 - 0.45 S 0.370 0.027 15

Initial Grouping by Reagent

Abbott FPIA 2 0.25 - 0.41 S 0.330 0.025 0.35 - 0.53 S 0.442 0.029 0.47 - 0.6 S 0.535 0.023 0.43 - 0.63 S 0.528 0.034 0.31 - 0.45 S 0.376 0.024 25

Initial Grouping by Sensitivity or Principle

Fluorescence polariz (FPIA) 3 0.25 - 0.41 S 0.330 0.025 0.35 - 0.53 S 0.442 0.029 0.47 - 0.6 S 0.535 0.023 0.43 - 0.63 S 0.528 0.034 0.31 - 0.45 S 0.376 0.024 25

Other 4 0.17 - 1.12 S 0.647 0.158 0.21 - 0.74 S 0.471 0.088 0.08 - 0.72 S 0.402 0.107 0.15 - 0.72 S 0.433 0.095 0.09 - 1.1 S 0.595 0.170 13

Total Population

Whole Population 5 0.11 - 0.64 S 0.377 0.089 0.3 - 0.61 S 0.454 0.053 0.42 - 0.63 S 0.526 0.034 0.36 - 0.66 S 0.512 0.050 0.15 - 0.69 S 0.418 0.089 40